Characteristics of the gluten-free diet.
\r\n\t
",isbn:"978-1-83962-547-3",printIsbn:"978-1-83962-546-6",pdfIsbn:"978-1-83962-548-0",doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!0,hash:"e5ba02fedd7c87f0ab66414f3b07de0c",bookSignature:" John P. Tiefenbacher",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/10765.jpg",keywords:"Managing Urbanization, Managing Development, Managing Resource Use, Drought Management, Flood Management, Water Quality Monitoring, Air Quality Monitoring, Ecological Monitoring, Modeling Extreme Natural Events, Ecological Restoration, Restoring Environmental Flows, Environmental Management Perspectives",numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:null,numberOfDimensionsCitations:null,numberOfTotalCitations:null,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"January 12th 2021",dateEndSecondStepPublish:"February 9th 2021",dateEndThirdStepPublish:"April 10th 2021",dateEndFourthStepPublish:"June 29th 2021",dateEndFifthStepPublish:"August 28th 2021",remainingDaysToSecondStep:"20 days",secondStepPassed:!1,currentStepOfPublishingProcess:2,editedByType:null,kuFlag:!1,biosketch:"A geospatial scholar working at the interface of natural and human systems, collaborating internationally on innovative studies about hazards and environmental challenges. Dr. Tiefenbacher has published more than 200 papers on a diverse array of topics that examine perception and behaviors with regards to the application of pesticides, releases of toxic chemicals, environments of the U.S.-Mexico borderlands, wildlife hazards, and the geography of wine.",coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"73876",title:"Dr.",name:"John P.",middleName:null,surname:"Tiefenbacher",slug:"john-p.-tiefenbacher",fullName:"John P. Tiefenbacher",profilePictureURL:"https://mts.intechopen.com/storage/users/73876/images/system/73876.jfif",biography:"Dr. John P. Tiefenbacher (Ph.D., Rutgers, 1992) is a professor of Geography at Texas State University. His research has focused on various aspects of hazards and environmental management. Dr. Tiefenbacher has published on a diverse array of topics that examine perception and behaviors with regards to the application of pesticides, releases of toxic chemicals, environments of the U.S.-Mexico borderlands, wildlife hazards, and the geography of wine. More recently his work pertains to spatial adaptation to climate change, spatial responses in wine growing regions to climate change, the geographies of viticulture and wine, artificial intelligence and machine learning to predict patterns of natural processes and hazards, historical ethnic enclaves in American cities and regions, and environmental adaptations of 19th century European immigrants to North America's landscapes.",institutionString:"Texas State University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"6",institution:{name:"Texas State University",institutionURL:null,country:{name:"United States of America"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"12",title:"Environmental Sciences",slug:"environmental-sciences"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"194667",firstName:"Marijana",lastName:"Francetic",middleName:null,title:"Ms.",imageUrl:"https://mts.intechopen.com/storage/users/194667/images/4752_n.jpg",email:"marijana@intechopen.com",biography:"As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophanides",surname:"Theophile",slug:"theophanides-theophile",fullName:"Theophanides Theophile"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1373",title:"Ionic Liquids",subtitle:"Applications and Perspectives",isOpenForSubmission:!1,hash:"5e9ae5ae9167cde4b344e499a792c41c",slug:"ionic-liquids-applications-and-perspectives",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/1373.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"57",title:"Physics and Applications of Graphene",subtitle:"Experiments",isOpenForSubmission:!1,hash:"0e6622a71cf4f02f45bfdd5691e1189a",slug:"physics-and-applications-of-graphene-experiments",bookSignature:"Sergey Mikhailov",coverURL:"https://cdn.intechopen.com/books/images_new/57.jpg",editedByType:"Edited by",editors:[{id:"16042",title:"Dr.",name:"Sergey",surname:"Mikhailov",slug:"sergey-mikhailov",fullName:"Sergey Mikhailov"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"878",title:"Phytochemicals",subtitle:"A Global Perspective of Their Role in Nutrition and Health",isOpenForSubmission:!1,hash:"ec77671f63975ef2d16192897deb6835",slug:"phytochemicals-a-global-perspective-of-their-role-in-nutrition-and-health",bookSignature:"Venketeshwer Rao",coverURL:"https://cdn.intechopen.com/books/images_new/878.jpg",editedByType:"Edited by",editors:[{id:"82663",title:"Dr.",name:"Venketeshwer",surname:"Rao",slug:"venketeshwer-rao",fullName:"Venketeshwer Rao"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4816",title:"Face Recognition",subtitle:null,isOpenForSubmission:!1,hash:"146063b5359146b7718ea86bad47c8eb",slug:"face_recognition",bookSignature:"Kresimir Delac and Mislav Grgic",coverURL:"https://cdn.intechopen.com/books/images_new/4816.jpg",editedByType:"Edited by",editors:[{id:"528",title:"Dr.",name:"Kresimir",surname:"Delac",slug:"kresimir-delac",fullName:"Kresimir Delac"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3621",title:"Silver Nanoparticles",subtitle:null,isOpenForSubmission:!1,hash:null,slug:"silver-nanoparticles",bookSignature:"David Pozo Perez",coverURL:"https://cdn.intechopen.com/books/images_new/3621.jpg",editedByType:"Edited by",editors:[{id:"6667",title:"Dr.",name:"David",surname:"Pozo",slug:"david-pozo",fullName:"David Pozo"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"54282",title:"Are Gluten-Free Foods Just for Patients with a Gluten-Related Disease?",doi:"10.5772/67523",slug:"are-gluten-free-foods-just-for-patients-with-a-gluten-related-disease-",body:'Gluten, the set of proteins that gives technological properties for bread making and other multiple processes, has been recognized since more than 60 years as the cause of celiac disease (CD). Gluten/wheat is also the cause of other disorders such as wheat allergies and more recently non-celiac gluten/wheat sensitivity [1]. Treatment of these conditions requires gluten/wheat dietary restriction. Gluten-/wheat-related disorders are more frequent now than a couple of decades ago; nowadays, their global prevalence is estimated by 5% [2]. However, due to their highly variable clinical expression, an important proportion of patients could be undetected. Considering this prevalence, the proportion of people who are currently on a gluten-free diet exceeds in more than five times the number of those who require gluten exclusion as a treatment for a diagnosed medical reason [3].
There are reports that about 30% of American people would like to eliminate gluten from their diet and the reasons are wide, perhaps influenced by misunderstood propaganda. Consumers stand out the idea that gluten-free products are healthier or that gluten-free diet would help them to lose weight and to improve their mental health or because symptoms they attribute to ingestion of wheat-containing foods [4, 5]. However, does the intake of gluten-free products really offer those benefits? And especially, is the gluten-free diet safe if auto-administered, or is it an adequate food regimen to be adopted by healthy people in the long term?
In this chapter, we discuss the main indications for a gluten-free diet and refer the current trends in food industry related to gluten-free foods market. Finally, we try to clarify the main benefits, disadvantages and metabolic risks that a gluten-free diet represents for patients with different bowel inflammation diseases or for other way healthy people without a medical diagnosis.
Celiac disease is an immune-mediated disease that affects the small intestine, precipitated by dietary gluten in genetically predisposed persons [6]. Patients suffering from this condition develop flattening and atrophy of intestinal villi, decreasing the absorption surface, and therefore there are reduction of digestive enzymes bound to membrane and poor absorption of vitamins and minerals. As a result, in addition to gastrointestinal manifestations, extra-intestinal alterations such as iron deficiency anaemia, loss of bone density and hormonal and skin disorders can be common components of celiac disease [7].
In spite of the recognition since so many years, until recently celiac disease was considered rare in the South American population and even inexistent in the Asian population. It is because of its association with the HLA-DQ2 genotype that is present in more than 95% of white European celiac patients, in which the expressed molecule is needed, but not sufficient for developing the enteropathy. Currently, it is well known that the Amerindian people expressing HLA-DQ8 haplotype alone or in combination with an HLA-DQ2 allele could suffer celiac disease [8, 9]. More recently, Wang et al. [10] found that Asian individuals with HLA-DQ9.3 are also prone to celiac disease.
Celiac disease prevalence has increased worldwide between 1 and 2% in general population during last decades, possibly due to that is better known and diagnosed and/or to changes in lifestyles, including more acceptation of the high wheat content of the occidental diet, in the last years [7].
In addition to celiac disease, there are wheat allergies with pathogenesis mechanisms well studied, and they have been characterized since long time ago [1]. According to the route of wheat exposure, they are classified as occupational asthma, rhinitis, hives, wheat-dependent exercise-induced anaphylaxis as well as food allergy that can manifest at the skin, gastrointestinal or respiratory level [1]. The common feature of wheat allergies is that they are IgE-mediated conditions and that their symptoms appear in minutes or up to 2 h after ingestion of wheat. It usually occurs in young children with a history of atopy, in whom gastrointestinal symptoms dominate, while in older people, the expression is dermatitis, respiratory disorders and, in extreme cases, anaphylaxis [11].
Since 2012, a new clinical entity related to the ingestion of gluten-containing food emerged as non-celiac gluten sensitivity, characterized by intestinal and extra-intestinal symptoms [12]. Because of the unknown pathogenesis of such gluten sensitivity, there are no biomarkers for diagnosis but exclusion of either celiac disease or wheat allergy [13]. The terminology non-celiac gluten sensitivity is a matter of debate because patients describe symptoms after ingestion of wheat products but the causative compound is unknown; therefore, it should been called non-celiac wheat sensitivity or just wheat sensitivity or wheat intolerance.
To identify specific sensitivity to wheat compounds, a strict exclusion of dietary wheat (including gluten) should be done and then two different challenges using purified wheat without gluten or gluten alone, to evaluate symptoms [13, 14]. However, an additional trouble for result interpretation could be that some non-gluten wheat proteins such as serpins, purinins, α-amylase/protease inhibitors, globulins and farinins are also antigens involved in the celiac disease humoral immune response [15].
On the other hand, irritable bowel disease, considered the prototype of all functional intestinal disorders, has a high prevalence among adults. Its diagnosis relies upon symptoms evaluation according to the Rome III criteria, because there are no specific biomarkers identified yet [14]. Its symptoms are exacerbated by food ingestion especially wheat, recognized as one of the relevant triggers. However, the responsible component among gluten, non-gluten proteins or fructans is unknown because all of them coexist in wheat and may induce symptoms associated with intestinal inflammation in human beings. Fructans belonging to fermentable oligo-, di- and monosaccharides and polyols (FODMAP) are compounds that elicit the clinical picture of irritable bowel syndrome, found in addition to wheat, in several dietary items, as some vegetables and fruits [14].
Therefore, as related to gluten- and/or wheat-related diseases, there are a wide spectrum including celiac disease, non-celiac gluten (or wheat) sensitivity, wheat allergies, FODMAP intolerance and other functional bowel diseases. The boundaries of each wheat-related disease are not always clear, inducing confusion regarding diagnosis [6] and dilemma on which diet and treatment should be applied [14]. In that way, it is not surprising that many people in developed countries decide by themselves to follow a gluten-free diet; only 15–16% of such diet followers have a medical diagnosis and prescribed treatment of gluten or wheat exclusion [16].
According to the Codex Alimentarius [17], the International Food Standards, foods for special dietary uses are “those foods which are specially processed or formulated to satisfy particular dietary requirements which exist because of a particular physical or physiological condition and/or specific diseases and disorders and which are presented as such” (Codex standard 146-1985; last modified: 2009). Additionally, there is a special standard for gluten-free foods defined as “foods for special dietary uses that have been formulated, processed or prepared to meet the special dietary needs of people intolerant to gluten” (Codex standard 118-1979; last modified 2015).
The former definitions mean that unlike foods for special medical purposes, which should be prescribed and supervised by medical doctors, gluten-free foods for special dietary uses do not need any prescription to buy them. They are commercially available, not only for gluten-intolerant individuals but also for any consumer which voluntary follows a gluten-free diet or eventually buy some of these popular products [18]. Nowadays, due to marketing strategies and trends related to healthy foods, as well as self-diagnosis of gluten-/wheat-related disorders, an important part of the population in developed countries is following a gluten-free diet. This diet is currently one of the three most popular food regimen in the world along with the low-carbohydrate and fat-free diets [5].
The trends have boosted the gluten-free and reduced-gluten foodstuffs market over the world. However, the boost of gluten-free foods is peaking because sales of gluten-free products grew more than 30% annually between 2010 and 2014. In the United States (USA), sales increased 47–86% (according to the source) between 2012 and 2013 [19, 20], while the growth was just 6% from 2015 to 2016 [19]. More than two years ago, the reason for eating gluten-free foods were 51% for improved health, 38% to feel better and 27% to lose weight; only 6% followed a medical-prescribed gluten-free diet [20]. In 2016 just 10% think gluten-free foods help to manage their weight, and few people consider that gluten-free foods are higher in quality than those with gluten, probably because people are better informed [19]. However, the market cost of gluten-free foods is still very important, reaching $1328 million of American dollars in 2016 [19].
Additionally, the Codex Alimentarius [17] indicates that foods made from naturally gluten-free ingredients or ingredients specially processed to remove gluten should contain no more than 20 mg/kg of gluten and foods specially processed to reduce gluten should content between 20 and 100 mg/kg, which is a decision determined at the national level. Thus, the actual gluten intake in a strict gluten-free diet, consuming 0.5–1.0 kg of labelled foods, is about 10–20 mg/day, while eating a reduced-gluten diet can accomplish up to 100 mg/day. It is not expected to eat more than 1 kg/day of labelled gluten-free foods because dietary intake includes other non-labelled as gluten-free as fresh fruits and vegetables.
The complete exclusion of dietary gluten is almost impossible due to the ubiquitous nature of gluten in industrialized foods, cross-contamination and inadequate food labelling. Therefore, the actual problem of celiac disease patients sometimes diagnosed as refractory to treatment, because symptoms do not abate, is the consumption of unknown gluten content of some called gluten-free foods. For instance, a study was carried out in the USA analysing 275 gluten-free–labelled foods and 186 non-labelled as gluten-free without wheat, rye or barley. Three of the gluten-free labelled (1.1%) were mislabelled, meaning almost 99% of compliance, while 36 out of 186 of non-wheat containing had more than 20 ppm of gluten, and 19 of them were higher than 100 mg/kg of gluten [21].
According to the Food and Drug Administration (FDA) of the USA [22], the labelled gluten-free foods that include “wheat” in the ingredient list as wheat starch, either before or after hydrolysis (glucose syrup or maltodextrin), should specify in the label that wheat has been processed to remove gluten according to the FDA regulation. This is because while these products are safe for celiac disease patients, these could be risky for people with any other wheat-related disease.
Currently, to prepare gluten-free bakery products, ingredients such as rice and corn flour, mixed with hydrocolloids and enriched with milk, egg or soybean proteins, are used [23]. In addition, there are alternative grains used as buckwheat, amaranth, quinoa and teff, as well as different starch sources as these of potato and cassava. To improve the overall quality of the products, enzymes as microbial transglutaminase and proteases are used [24]. The European Food Information Council (EUFIC) and the FDA of the USA recognize all of the cited food additives as safe; also, different regulations accept them as gluten-free. However, some of them could affect the health of patients with gluten-/wheat-related and/or other gastrointestinal diseases.
Some of the food additives as emulsifiers and microbial transglutaminase could alter the integrity of tight junctions between the epithelial cells of the small intestine, increasing the paracellular intestinal permeability. Tight junction dysfunction or “leaky gut barrier” is a common feature in several autoimmune disease pathogenesis such as celiac disease and type 1 diabetes [6, 25]. It is because the opened tight junctions allow the entry of dietary antigens and trigger an immune cascade that can lead to autoimmunity in susceptible people [26]. Furthermore, leaky gut barrier function and immune activation are also important factors associated with irritable bowel disease. In this syndrome, the ingested food components can induce infiltration and activation of mast cells after passing the gut barrier, leading to the development of symptoms [14].
The problem is that a considerable proportion of the general population consider themselves as affected due to symptoms and dangerously decide to self-diagnose with gluten or wheat intolerance or sensitivity and adopt self-prescribed diets [27]. Even more, the non-celiac gluten or wheat sensitivity described in adults has little evidence in children, with no data supporting the health benefits of a gluten-free diet. If the children follow a gluten-free diet without guidance of an experienced nutritionist or physician, it can lead to unbalanced nutrition and health complications [28].
Another additive used in gluten-free foodstuffs is inulin-type fructans because of their prebiotic properties which provide structure and gas retention during baking. Its addition to the mix dough improves the quality of gluten-free bread, enhances sensorial acceptance and increases the fibre content, reducing glycaemic response and inducing a better nutritional quality [29]. Furthermore, to help to improve the decreased calcium absorption of patients with celiac disease, the gluten-free bread can be fortified and added with inulin-type fructans increasing calcium bioavailability [30]. However, for patients with irritable bowel disease and/or FODMAP-intolerant people consuming such gluten-free bread added with fructans, its intake could be a problem.
The transglutaminase family is a set of enzymes capable to bind a protein chain with other one, through covalent bonds, inducing a net formation. If there is no amino acid residue with an amino lateral in each two neighbour chains, transglutaminases release the amino radical, producing glutamate instead glutamine, for instance, in a called deamidation process. The microbial transglutaminase (mTG) is widely used in the food industry, especially for industrially processed products that naturally do not contain gluten as well as in gluten-free bakery products for enhancing quality. Its addition simplifies the elaboration processes and reduces the production cost while improves the texture, elasticity and appearance and even reduces the caloric content. However, the products of the enzymatic activity and homology of mTG with the human tissue transglutaminase (tTG), a key component in celiac disease pathogenesis because of its deamidation capacity, could elicit the exacerbated immune response of celiac patients.
The enzyme mTG can deamidate/transamidate gluten in the same way as tTG does and can change the protein antigenicity leading to a higher antigenic load [31]. Regarding this, Dekking et al. [32] found that gluten-specific T cells recognize gluten peptides deamidated by mTG, so they recommend that patients with celiac disease should avoid the consumption of products containing it, in order to control the disease. In another study, the reactivity of IgA of celiac patients against prolamins of wheat and gluten-free breads (maize and rice flours), mTG-treated or not, was evaluated. Sera pool from celiac patients presented IgA higher titres against prolamins of mTG-treated wheat or gluten-free breads than against mTG-untreated ones. The electrophoretic pattern of gluten-free bread prolamins was modified by the mTG treatment, and a new 31 kDa band originated in maize was recognized by IgA of some patients with CD [33].
Therefore, some additives of the gluten-free foods can induce negative effects for patients with different wheat-related diseases and even for those with celiac disease depending of the added compounds. The gluten-free food formulations should be carefully designed to prevent complications as described above.
A recognized problem associated with gluten-free diets is that it could induce nutritional imbalance, especially in children. Gluten-free cookies and some sweet products at the Italian market have more than 20% of fat, and 7.5% of them are saturated fat [34]. In addition, gluten-free products contain less vitamins and minerals and frequently have lower protein content than the wheat-containing food products. It is because wheat flours are fortified with vitamins and minerals in several countries; hence, alternative flours for gluten-free foods should be also fortified. Despite this, most of the gluten-free products commercially available are not fortified, and those already fortified premium products are not widely available and have higher costs that are not accessible to the majority of consumers [35].
In addition to other limiting issues, gluten-free breads had a higher glycaemic index than the conventional gluten-containing breads according to the results of a comparison of 20 commercial breads of the major European brands [24]. Formerly, Mazzeo et al. [34] published a food composition database including 60 gluten-free food representatives of different categories sold on the Italian market (more than 50% of them are distributed all over Europe). Almost all the gluten-free products were high in available carbohydrates, with approximately 50% of sugar content in cookies, breakfast and sweet products, which results in a high glycaemic load when consumed.
However, due to their hydrocolloid content, half of the Italian gluten-free foods formerly described presented a dietary fibre content at least of 3% [34]. In contrast, Vici et al. [36] in a wide review between 1990 and 2015 found gluten-free diet to be poor in fibre due to avoidance of grains and because products are usually made with starches and/or refined flours. Coinciding with them, Estevez et al. [35] found, when analysing the basic basket of gluten-free products available in Chile, that regular wheat-based foods like biscuits and noodles contain 50% more fibre than their gluten-free equivalents, which also contain 24% less protein, on average. In addition, dairy products, like gluten-free cheese and yogurts, can have up to 52.4% more sodium than the regular ones.
All these compositional characteristics of gluten-free products have a direct impact for evaluation of diet as a whole. Thus, in another study in Spain [37], the average diets of 58 adults with celiac disease were analysed, finding that women in this regimen tend to decrease the consumption of protein and fibre, increasing fat, while men increase their intake of animal protein, compensating the excluded protein from cereals. In both genres, the authors detected an increase in the total caloric intake when comparing to a similar diet composed of regular foods.
As stated by Pellegrini and Agostoni [18], the gluten-free foods should improve their nutritional quality to decrease the risk of later chronic degenerative disorders.
To follow a strict gluten-free diet is a broad dietary change, which can be associated with several risks. Nutritional inadequacy of this diet can compromise the intake of minerals, especially in children and adolescents. The gluten-free diet can be associated with reduction of fibre intake because patients elude wheat and other cereal fibre sources. The lack of fortification can affect health and quality of life, increasing the risk of anaemia, osteoporosis and constipation, mainly in patients whose disease, which includes deficient intestinal absorption, already predisposes them to these complications.
All of the previous comments together do not mean that the gluten-free diet was a bad choice. As shown in Table 1, for people with diagnosed celiac disease, the dietary gluten exclusions are the only treatment option to avoid and/or reduce symptoms and prevent complications in the medium and long term. Even for individuals with wheat allergy, non-celiac gluten/wheat sensitivity and intestinal bowel syndrome, except for those with FODMAP intolerance who need additional dietary changes, the gluten-free diet could be able to reduce gastrointestinal symptoms because the gluten-free foods do not contain wheat with its triggering compounds.
Advantages | Disadvantages | Risks |
---|---|---|
|
|
|
Characteristics of the gluten-free diet.
Figure 1 shows a hypothetic design to discriminate among the wheat components possibly related to each wheat-related disease, for dietary recommendation. Therefore, if were possible to know the type of compounds responsible or related to non-celiac gluten/wheat sensitivity and irritable bowel syndrome, the gluten-free diet could be not the best treatment for patients suffering from such diseases. In many cases, a low FODMAP diet may offer a higher chance of symptomatic response; however, the gluten-free diet involves attacking a specific pathogenic factor for celiac disease based in its pathogenesis mechanism. If the injurious nature of other wheat proteins is part of the genesis of visceral hypersensitivity or other gut-related physiological changes, it is very important to look for the key compound to design the right diet [14].
Hypothetic design to discriminate among the wheat components possibly related to each wheat-related disease, for dietary recommendation.
Due to the technological difficulty for obtaining high-quality gluten-free products and to their lower market demand than their conventional food counterparts, they can be up to 300% more expensive [35]. Therefore, an option for people with gluten-related disorders is the home preparation of foods from unprocessed sources to devise a balanced gluten-free diet. Anyway, it is highly recommended to follow the nutritionists or medical specialist instructions as well as to do the periodic analysis of the nutritional status, especially for children, adolescents and risk persons, to maintain the best balance.
After the previous discussion, it is clear that the gluten-free diet is not a good option for persons without diagnosis of gluten hypersensitivity, especially when it relies in the abuse of industrialized products. If healthy people decide to follow a gluten-free diet because they consider it is healthier or fashionable, they should be very careful to accomplish the nutrition balance.
The differential diagnosis of the actual disease among gluten-/wheat-related disorders has important prognostic and therapeutic implications for the patient. An undiagnosed celiac disease in children may result in growth restriction, emaciation, osteoporosis, dental problems and in acute cases electrolyte imbalance and hypocalcaemia that can be life-threatening [38]. In contrast, following a gluten-free diet in the absence of symptoms or diagnosis might mask underlying diseases.
In the last decade, due to easier access to information, self-diagnosis of gluten-/wheat-related disorders has increased, and because there is more wide availability of gluten-free foods, many people follow a gluten-free diet. This implies that one person recognizes his own symptoms and without medical advice associates them with any of the previously described diseases. Subsequently, one adopts the gluten-free diet looking for improvement. This can generate benefits in the short term in those cases where the symptoms decrease. Golley et al. [16] published a study of 1184 Australians surveyed from the general population, where 10.6% were already on a gluten-free diet, while just 1.2% of them had formal diagnosis of celiac disease. However, 80% of the followers do to relieve symptoms such as bloating, abdominal discomfort, asthenia and adynamia. Perhaps the placebo effect is part of these results while a strict following was not registered.
Self-prescription of gluten-free diet may cause unsuccessful medical diagnosis because gluten consumption is necessary to obtain an accurate and reliable blood test and biopsy. When the patient is already on a gluten-free diet, a challenge with gluten is done for a long time before performing the diagnostic test [39].
Having a medical diagnosis influences the type of diet to follow, for example, gluten-free, wheat-free or restricted in FODMAP (Figure 1). In addition, depending on the nature of the disease, the duration of treatment may differ between being temporary or required lifelong as for celiac disease. Favourably, a diagnosis can bring relief to a person, eliminates uncertainty, generates social acceptance, facilitates adherence to the diet and can help convince the family about the importance of the diet and the negative consequences of lack of attachment [39].
Some followers of the gluten-free diet do not have gastrointestinal symptoms and decide to enrol in a gluten-restricted regimen for other causes. In the Golley study [16], this subgroup represents up to 20% of the people in a gluten-free diet, referring reasons such as having a family member with celiac disease, personal taste or preference. In the USA, the main reason to follow a gluten-restricted diet is that people believed that gluten-free industrialized products were healthier than regular ones [40]. Although it is changing nowadays, the market cost of gluten-free foods is still extremely high, which means that there are so many undiagnosed people following a gluten-free diet.
The fact that such a large proportion of the population is in such gluten-free–restrictive regimen forces health personnel to be alert and well informed about the nutritional adequacy of the gluten-free diet in general, in order to guide and counsel this special group. Healthy people on a gluten-free diet may unnecessarily limit the variety and quality of their diet [41]. Believing that these products are healthier or considering them suitable for weight loss can cause an overconsumption of gluten-free energy-rich and nutrient-poor products and could result in the opposite way, promoting weight gain [42].
A new aspect in gluten-related disease and gluten-free diet is the intestinal microbiota. The gut microbiota and its products play an important role in the pathophysiology of celiac disease, and dietary composition can modulate the structure of microbiota. Bonder et al. [5] found that in healthy people, the gluten-free diet did not induce major inflammatory or metabolic changes in gut function after 1-month intervention, in contrast to people with celiac disease. However, they observed a decrease in the proportion of Veillonellaceae, considered a pro-inflammatory family frequently reported in patients with inflammatory bowel syndrome. Possibly, it could be another reason explaining why the gluten-free diet benefits this group of patients.
A current very common practice in athletes is to follow the gluten-free diet, perhaps influenced by news about a famous tennis player with celiac disease diagnosed five years ago. According to Lis et al. [43], more than 40% of endurance athletes follow it at least half the time. They consider the idea that these foods, in addition to being healthier and useful for controlling their weight, relieve systemic inflammation and improve athletic performance. However, the double-blind, placebo-controlled, crossover study by Lis et al. [43], in 13 competitive cyclists, found neither positive nor negative effects on performance, gastrointestinal symptoms or systemic inflammation measured as cytokine responses: IL1A, IL-6, IL-8, IL-10, IL-15 and tumour necrosis factor alpha. For all these reasons, it is recommended that athletes seek nutritional advice to ensure that their diet meets the special requirements that their sport implies, before deciding to start a gluten-free plan.
Due to the global epidemic of malnutrition, where extreme problems such as obesity and emaciation prevail together, public health policies should implement a promotion to increase the consumption of real healthy foods, such as whole grains, fresh fruits and vegetables, and reduce the consumption of discretionary foods [41].
Thus, the awareness of gluten effects on healthy and diagnosed individuals is summarized in that a gluten-free diet should be understood as a therapy and therefore only to be prescribed and supervised by specialists. Finally, to eat occasionally a gluten-free foodstuff does not need any prescription but money to buy it.
The development of cryopreservation techniques has made possible the use of frozen and thawed gametes and embryos aiming at reproduction, by means of assisted reproductive techniques (ART). Cryopreservation allows to banking gametes for later use, including also the possibility to be used by other individuals, as in donor treatments. Effective techniques such as in vitro fertilisation (IVF) and intra-cytoplasmic sperm injection (ICSI), worldwide applied, offer a high efficacy by the creation of supernumerary embryos. As recognised downsides of IVF/ICSI treatments include the high prevalence of perinatal complications due to multiple births, the recommended practice of transferring fewer embryos in the fresh IVF treatment cycle, with the goal of performing single embryo transfer and the cryopreservation of remaining embryos for their later use in frozen-thawed cycles, one at a time, is currently the trend [1]. The cumulative chance to achieve pregnancy and live-birth through IVF/ICSI treatments is thus enhanced by the later use of thawed embryos in separate treatments.
\nThe methods for cryopreservation of embryos and gametes have demonstrated effective and safe, and have developed towards the achievement of a clinically established level. These methods are also currently being offered to patients suffering of cancer, due to the risk of infertility associated with certain cancer treatments, or to individuals with conditions that have an inherent risk of premature gonadal insufficiency and infertility, aiming at fertility preservation [2].
\nAlthough embryo cryopreservation has historically been regarded as the first-choice technique for fertility preservation, social, ethical and legal reasons usually restrict its use to couples who have entered into a committed long-term relationship. However, women without a partner may attempt this possibility using a sperm donor. Furthermore, this issue has also been shown to translate to fertility preservation undertaken electively, with one study finding that >80% of patients undergoing oocyte preservation by choice were single at the time, and that lack of a partner was by far the most common reason for not pursuing child-bearing earlier [3].
\nAs such, the cryopreservation of gametes affords individuals an increased level of reproductive autonomy, and ensures that fewer patients are faced with the extraordinarily difficult decision of later reproducing with a partner who may no longer be ideal, or not reproducing at all. Here, the most common indications for gamete cryopreservation in both males and females and embryo cryopreservation will be discussed, along with their clinical outcomes, necessary considerations and future perspectives.
\nAlthough semen cryopreservation has remained an established technique for many years, the cryopreservation of mature oocytes was considered experimental by the American Society for Reproductive Medicine (ASRM) until 2013 [4]. As such, this relatively recent development has paved the way for an explosion of social fertility preservation (‘social freezing’), found by a HFEA report to have increased more than two-fold between 2013 and 2016. In fact, a 10% increase in the number of egg freezing cycles was reported from 2015 to 2016 [5]. In a field which was once dominated by fertility preservation following medical diagnosis, this represents a dramatic paradigm shift, which must be regulated to ensure transparency for, and protection of, the prospective patient. This differs from traditional approaches to non-elective fertility preservation, where patients who may be younger or have no desire to delay childbearing are faced with a high likelihood of complete infertility following resolution of their disease. Therefore, such conditions encompass those that directly cause premature ovarian insufficiency (POI) such as bilateral benign ovarian tumours, severe recurrent endometriosis or genetic disorders (e.g., Turner’s syndrome), and conditions that indirectly result in POI such as malignant or non-malignant diseases that require the administration of gonadotoxic chemo- or radiotherapy [6].
\nWhilst there is a tendency to focus primarily upon female infertility due to the intrinsically finite nature of female reproductive biology, it must be remembered that males are also distinctly susceptible to gonadotoxic agents, with one study reporting that up to 60% of male cancer survivors experience fertility impairment [7]. In fact, malignant diseases are amongst the most significant indirect contributors to infertility worldwide, with some of the most commonly-used classes of chemotherapeutics, alkylating agents, having been shown to induce POI in 42% of women treated [8]. The situation is further complicated by the widespread use of novel targeted therapies whose impact upon fertility is largely unknown [9]. These advances in cancer treatment efficacy (coupled with societal pressures to delay childbearing) have led to an increasing proportion of cancer survivors who wish to further add to their families, resulting in increased public awareness of treatment-induced subfertility, increased demand for fertility-preserving procedures, and the emergence of a brand-new field: oncofertility [10, 11]. This new discipline is badly-needed, providing patients with essential information that will impact upon their treatment decisions and future family planning, and aiming to disrupt the traditional lack of emphasis placed on iatrogenic infertility in the oncological sphere [11, 12, 13].
\nAnother newly-emerging paradigm in gamete cryopreservation is its implementation as a timesaving method in fertility treatment. Age is the most significant determinant of IVF cycle outcome, meaning that older females who present for treatment may be considered for multiple consecutive rounds of ovarian stimulation and egg collection, thereby facilitating the freezing of large numbers of eggs which can later be fertilised and transferred [14]. This is a significant advantage for couples who may want multiple children, or who find the storage of a large number of embryos ethically questionable. It is open to debate whether this application should be considered medical or social, but as technology advances, it is important we consider such applications that lie within the ‘grey areas’ of medicine.
\nSperm cryopreservation is the only established fertility preservation method in post-pubertal males, and has been in clinical use for over 50 years [15]. Its early adoption to the clinical realm is attributed to the accidental discovery of the cryoprotective properties of glycerol on sperm cells, their abundance for experimental uses and their small size. This latter property is an extremely important one, reducing the likelihood of damaging intracellular ice crystal formation during the freezing process. Whilst cryopreservation by slow freezing protocol was the first method used successfully, it causes extensive chemical and physical damage to sperm cell membranes, with only 60% of sperm regaining motility post-thaw [16]. Comparative studies have demonstrated that non-standard methods of rapid freezing (vitrification) using liquid nitrogen give better post-thaw motility rates and alter protein expression profiles less, as well as being more time- and cost-efficient [17, 18]. Whilst both methods result in a significant reduction in viability, the (generally) high number of spermatozoa per sample means that lower survival rates are acceptable. As such, either cryopreservation method may be used effectively. This relatively low bar for post-thaw viability contrast hugely with oocyte cryopreservation, where the numbers of gametes collected tends to be small, and therefore more stringent protocols and attrition rates are required.
\nSperm samples for cryopreservation are usually obtained by masturbation, but if in the cases of azoospermia, males who are unable to provide a sample (e.g., for psychosocial or physical reasons) or those who have previously undergone a vasectomy, surgical techniques may be employed. These include epididymis aspiration, testicular needle biopsy (TESE) or needle aspiration (TESA), with TESE having impressive success rates of 85%, even following chemotherapy for testicular cancer [19]. It is important to note that although these methods of sperm retrieval are effective, all require that the patient is able to produce spermatozoa, even at dramatically decreased levels. Options are extremely limited for patients whose Sertoli cells are non-functional, or pre-pubertal males, with the cryopreservation and autotransplantation of spermatogonial stem cells (SSCs) still classified as experimental, but showing promise in animal models [20]. In vitro maturation of SSCs, or SSC derivation from induced pluripotent stem cells (iPSCs) are also avenues under investigation [21].
\nWhilst both the American Society of Clinical Oncology (and almost all other) guidelines recommend that fertility preservation be offered to pubertal males before commencement of gonadotoxic treatment, only 25% of eligible males in the relevant cohorts bank sperm. These statistics are surprisingly low, especially when one considers the generally non-invasive nature of semen sample collection, and the wealth of prospective studies supporting that viewpoint that the overwhelming majority of men diagnosed with cancer wish to have children later in life [22]. One such study reported that 43% of patients surveyed ranked reproducing as a ‘top 3’ life goal [23]. It is therefore apparent that a disconnect exists in male fertility preservation that is not present to the same degree in the female equivalent. This may be due to routinely poor counselling by clinicians, but it is also possible that the priorities of young male patients may not adequately reflect their later life goals, or that male stoicism might affect the decisions made. Equally, the perceived high cost of cryopreservation and storage might have a role to play, even though robust cost-benefit analyses have shown sperm cryopreservation to be more cost-effective than post-therapeutic fertility management [19]. It has been evidenced that long-time storage does not seem to affect the fertilisation potential of sperm, as recently reported after 40 years of storage [24].
\nIn contrast to spermatozoa, mature (MII) oocytes are large, fragile cells that are much more susceptible to water retention and ice crystal-mediated damage. Furthermore, addition of cryoprotectants may result in osmotic stress, with the cumulative effect of these stressors manifesting as thickening of the zona pellucida, premature cortical granule exocytosis and meiotic spindle disruption [25, 26]. Although this disruption of the meiotic spindle appears to be transient in almost all cases, there is robust evidence to show that cryopreservation negatively impacts oocyte gene expression and proteomics, with some cryoprotectants even shown to alter maternally-derived proteins which support early oocyte development [27, 28, 29]. The net result of this is a ‘stressed’ oocyte which is difficult for spermatozoa to penetrate and fertilise. As such, the clinical applications of oocyte cryopreservation were limited until the inception of the ICSI technique in 1992 [30], with the first pregnancy derived from frozen oocytes following in 1997 [31].
\nAnother quantum leap forward in the efficacy of oocyte cryopreservation came with refinement of freezing protocols. Similar to the paradigm change seen in spermatozoa cryopreservation, vitrification (fast freezing) techniques were pioneered, first producing a live birth in 1999, and then being further improved by Japanese groups in 2003 [32, 33]. In contrast to the small increase in efficacy seen with the introduction of vitrification in spermatozoa cryopreservation, however, vitrification of oocytes seems to greatly increase post-thaw oocyte survival and fertilisation rates, with a 2014 Cochrane review finding a relative increase in oocyte survival of 29%, and a 19% increase in fertilisation [34]. An additional meta-analysis of three RCTs in 2016 reported a 16.1% increase in survival (RR = 1.23, 95% CI: 1.02–1.49; P = 0.031) [35]. The efficacy of the vitrification technique was further confirmed when a large prospective study of Spanish egg-donation programmes could not detect any statistically significant difference between using fresh donor eggs, when compared to vitrified frozen eggs [36]. It is important to note, however, that both of these techniques are inherently operator-dependent; with vitrification especially variable due to the need to complete the process within seconds [37]. This is an important caveat, and highlights the importance of training and upskilling, especially when considering the variable experience that operators may have within the same fertility clinic. It must also be clarified that the survival rates of oocytes (and the number collected) are likely dependent on the age and disease status of the donor, meaning that the extremely high survival rates of thawed oocytes reported by some studies on donor eggs (in excess of 96%), may not be truly representative for a significant proportion of patients who undergo fertility-preserving treatment [38].
\nIt is clear, therefore, that the path to the clinic for oocyte cryopreservation has not been a straightforward one, with the early, highly-ineffective methods of oocyte cryopreservation making it an unrealistic and imprudent option for females in urgent need of fertility preservation, such as oncology patients. Cancer in reproductive age is twice as common in females as in males, and more than half of those diagnosed are expected to undergo treatment that compromises their fertility [39]. One large retrospective study highlighted this, indicating that whilst the incidence of treatment-related acute ovarian failure (AOF) was approximately 10%, these figures greatly misrepresent the total age-specific impact on fertility, with 40% of those not reporting AOF encountering infertility by the age of 35 [40]. Furthermore, the probability of early menopause was ‘at least’ 25% by age 30 [40]. It is likely, therefore, that effects on fertility may often relate to a reduction in the overall number of primordial follicles, and may therefore remain undetected until later in life. In a society where increasing numbers of women are choosing to delay childbearing, this may mean that women who are presumed to have normal reproductive activity following resumption of menstruation may not try to conceive as early as they are able to, and then later encounter difficulty.
\nIt is important to consider that patients undergoing fertility-compromising cancer treatments may only have sufficient time for one round of ovarian stimulation and egg collection before their treatment must begin. This process of controlled ovarian stimulation (COS) followed by egg collection generally takes approximately 2 weeks to complete, with patients able to start chemotherapy within 48 h of completion. Whilst concerns had initially been raised about the administration of such high doses of exogenous gonadotrophins to patients with hormone-sensitive cancers (e.g. breast, ovarian), effective and safe stimulation protocols using aromatase inhibitors have been developed and shown to result in no increased risk of recurrence in breast cancer, after a mean 5-year follow-up period [41]. In addition, the use of GnRH antagonist regimens (in place of the usual GnRH agonist regimens) allow ovarian stimulation to be started at any point in the menstrual cycle (‘random-start protocols’), thereby minimising treatment delays. These GnRH antagonist regimens have been shown to result in the collection of similar numbers of mature oocytes and produce similar fertilisation rates [42]. Moreover, they have been shown to result in a lower risk of ovarian hyperstimulation syndrome (OHSS) than conventional protocols [43].
\nAs such, refinements in cryopreservation techniques and stimulation protocols represent incredibly important steps for cancer (and elective) patients, increasing both the safety of oocyte collection and the likelihood of a live birth following completion of treatment.
\nAs outlined above, the cryopreservation of gametes is a technically difficult and expensive process. As such, it is essential that the true success rates of these procedures be analysed using clinical endpoints, in order to prevent delays to treatment, unnecessary harm to patients and to disrupt the growing belief amongst the general proportion that egg freezing constitutes an infallible ‘insurance policy’ against age-related fertility decline.
\nIn order to assess the success of cryopreservation we must first examine the parameters by which success is gauged. The most realistic way to evaluate the efficacy of cryopreservation techniques (and indeed individual clinics) is through the comparison of live births achieved per oocyte thawed. Although this may seem obvious, there is a growing propensity for some clinics (especially those who derive a significant proportion of their income from social egg freezing) to display these statistics in a manner that makes them appear more impressive. For example, some success rates might be represented using clinical pregnancy rates per thaw cycle; with some studies reporting this to be as high as 78% [44]. This figure is not an accurate representation of the reality faced by most patients, with the largest reported study of 3610 vitrified oocytes producing an oocyte survival rate of 90%, translating to a clinical pregnancy rate of 48% and an ‘oocyte-to-baby’ rate of just 6.5% [45]. If this same study were to be presented alternatively, it could be quoted as a delivery rate of 78.8% per oocyte donation cycle. As such, it is clear that there must be further efforts to homogenise how ‘success’ is calculated, and increased scrutiny of how these results are presented to potential patients. It is essential, also, to note that this data (and indeed almost all data on oocyte cryopreservation) has been generated from oocyte donation programmes. This is significant because oocyte donors tend to be carefully-selected, young individuals, whose eggs are likely to be of greater quality than the average patient wishing to engage in autologous fertility preservation. In fact, this viewpoint is supported by findings that only 32% of patients freezing their eggs were below the age of 35, and recent data showing reduced yield of oocytes collected in oncology patients versus matched controls [5, 38, 44]. As such, it is likely that the true likelihood of a successful live birth for patients in these groups is significantly lower than the figures generated by current data. It is essential, therefore, that the increasing availability of data from non-donation sources be interpreted and used to validate the statistics that are currently quoted.
\nThe largest study using data collected from outside of egg donation programmes was carried out by Cobo et al., who examined the reproductive success of 1468 women undergoing elective oocyte cryopreservation for non-oncologic reasons [46]. Their data clearly demonstrates the impact of age at freezing upon potential success, with those who froze at or before the age of 35 having a 53.9% likelihood of a live birth per ET, whilst those freezing at or above the age of 36 had a 22.9% chance. This viewpoint was echoed by a recent HFEA report, who described patient age at freezing as ‘the most important factor’, whilst age at thaw was not determined to have any statistically significant impact [5]. The same study also demonstrated the importance of the number of oocytes obtained to vitrify in increasing chanced of a live birth, with an increase from 5 to 8 oocytes producing the most significant increase in LBR (8.4% per oocyte if <35). Whilst an average ‘oocyte-to-baby’ ratio is omitted, it is estimated to be significantly lower than the 6.5% achieved in donor programmes. Whilst this is an interesting figure, it is likely that it does not provide as clear a picture of the factors that impact oocyte viability as that provided by age-bracket stratification.
\nConsequently, we can conclude that the number of viable oocytes available for fertilisation is a clear determinant of the likelihood of successful pregnancy. The technique used to freeze and thaw the oocytes retrieved is thus of the utmost importance, with a multitude of studies confirming the advantages provided by vitrification protocols, both in terms of post-thaw oocyte survival and reported pregnancy rate. In fact, multiple studies reported the clinical pregnancy rate (CPR) to more than double when compared to slow-freezing protocols [47, 48]. In addition, there is increasing scrutiny on the impact that the rate of warming can have on post-thaw oocyte survival and characteristics. In fact, Mazur and Seki reported oocyte survival >80% when ultra-rapid warming was carried out, even when using traditional slow-freeze protocols. Further expanding on this, they demonstrated that such methods could be used to reduce the concentrations of cytotoxic chemoprotectant required for the vitrification process [49]. Interestingly, a recent meta-analysis of five studies concluded that there was no significant difference between the fertilisation rates, embryo cleavage or pregnancy rates achieved when using fresh versus vitrified oocytes [50]. This viewpoint is supported by recent data supplied by the HFEA, who concluded that the birth rate per embryo transfer (PET) was rising to over 19%, and within 2% of the overall IVF birth rate PET [5]. In addition, multiple studies have demonstrated that the length of storage has no effect on pregnancy rates or outcomes [45, 51]. As such, it is reasonable to conclude that cryopreservation techniques have advanced to such a stage that significant future improvements in success rates will likely relate to methods of increasing the yield of oocytes collected per stimulation cycle, or in the methods used to select the embryos to be transferred.
\nThe above discussion is necessarily focused on female gametes, as spermatozoa quality has traditionally been seen to be of less importance owing to the large number usually obtained per collection and their high survival rate. It is also worth noting that studies have found no correlation between sperm quality and disease stage in oncology patients [52]. In addition, the advent of ICSI has meant that even ‘poor quality’ sperm samples with low motility scores can be used to produce a viable embryo. That said, it is almost certain that there exist intrinsic variations in spermatozoa quality that currently evade detection, driving increased research into how we select the sperm we use for fertilisation, both in the context of conventional IVF, and in fertility preservation. The artificial techniques discussed have abrogated the physiological selection methods inherent to the natural reproductive process, paving the way for a growing need for the ‘unnatural selection’ of favourable gametes via novel biomarkers or growth characteristics. Ongoing avenues of such research include the assessment of spermatozoal DNA fragmentation rates (although evidence is not yet conclusive), and promising future avenues such as the stratification of sperm quality via spectrophotometric analytical techniques such as Raman spectroscopy [53]. In fact, the latter method would allow andrologists to select spermatozoa on the basis of both their homeostatic and epigenetic context [54].
\nIt follows that an essential aspect of any discussion on the clinical outcomes of gamete cryopreservation must be that of perinatal outcomes. It is often easy to rely on pregnancy rate as the sole benchmark of a successful preservation cycle, but serious consideration must also be given to whether the progeny created are morphologically, genetically and developmentally ‘normal’. Reassuringly, a number of analyses, one of 165 pregnancies and another of 936 infants, have found a comparable incidence of congenital abnormalities in infants born following oocyte vitrification, conventional IVF and natural pregnancy [55, 56]. There is also a growing body of evidence, however, that IVF may trigger epigenetic disruption in the developing embryo, potentially causing the slightly lower birth weights observed amongst children born as a result of these techniques [57]. That said, it is also possible that these differences are related solely to the increased ages of the patients within the IVF cohort. A long-established relationship exists between increased parental age and genetic dysfunction, with increased maternal age being linked to abnormal meiotic spindle function, and therefore the induction of gross chromosomal abnormalities such as Trisomy 21 (Down’s syndrome) [58]. Similarly, it has been shown that the higher prevalence of single point mutations seen in children born to fathers of more advanced age is attributable to the higher number of mitotic replications that these germ cells have experienced [59]. It is thought that this is a direct cause of the increased rates of neurodevelopmental disorders, leukaemias and stillbirths seen in this paternal cohort [60]. As such, although age has a strong positive correlation with adverse perinatal outcomes, no cryopreservation-specific (or indeed fertility treatment-specific) causal relationship has yet been reliably established.
\nIn fact, the most common perinatal outcomes that are directly attributable to IVF are due to multiple pregnancies. These usually occur as a consequence of the transfer of more than one embryo, and may result complications such as premature birth, intrauterine death and conversion to caesarean section [61]. Whilst this, and complications associated with advanced maternal age, certainly remain considerations in the fertility preservation sphere, the patients concerned tend to have fewer options and less time to achieve a successful pregnancy, making the delivery of multiple children more serendipitous than it otherwise might be. Indeed, as the average age of childbearing increases (due, in part, to ART), it is arguable that discussion of such ‘difficult pregnancies’ will be of less future importance, as prospective patients will almost always opt to try to conceive in the face of an increased risk of poor perinatal outcome, instead of not attempting to conceive at all.
\nIn conclusion, although the oocyte conversion rates discussed above might seem extremely poor at the outset, it must again be stressed that modern assisted reproduction technologies circumvent the physiological selection mechanisms that serve to ensure only the most viable gametes survive. Success rates using cryopreserved gametes are almost comparable to those achieved using fresh gametes, and therefore it is reasonable to expect the efficacy of both techniques to advance in parallel as our knowledge and gamete selection methods improve. The Table 1 presents several methods currently used to improving gamete selection for cryopreservation.
\nTechnique | \nDescription | \nEvidence | \n
---|---|---|
Pre-freeze swim-up preparation (spermatozoa) | \nTraditionally, sperm selection via preparative techniques was undertaken post-thaw. There is increasing evidence, however, to show that such swim-up techniques should be performed before cryopreservation to produce the highest percentage of viable spermatozoa. It is theorised that cytokine release from immune cells that are inadvertently included in cryopreserved samples may damage spermatozoa quality, and that this could be avoided using these pre-freeze techniques. This viewpoint has been supported by data from recent trials. | \nPetyim et al. [111] | \n
Rate of cooling | \nAs evidenced by the aforementioned increases in gamete quality using vitrification techniques, the rate of cooling during cryopreservation is extremely important. As such, efforts have been made to dramatically decrease the volume of the solution in which oocytes are vitrified (now 0.1–2 μL). To facilitate this, specialised carriers have been developed, including both open and closed systems. Comparative analysis of these two categories of systems has demonstrated similar oocyte survival rates, but significantly increased cytoplasmic vesicle presence (and theorised reduction in quality) in oocytes frozen using the closed system. | \nBonetti et al. [112] | \n
Low-CPA protocols | \nProtocols that employ low concentrations of cryoprotectants have the potential to combine the positive aspects of vitrification and slow-freezing, without their respective associated disadvantages. Although such protocols have been impractically complex and time-consuming, recent advances in quartz micro-capillary techniques are showing promise. | \nChoi et al. [113] | \n
Single-gamete analysis | \nAlthough not yet adequately optimised for clinical use, analysis of individual gametes has the potential to revolutionise how ART is carried out. The increasing need for artificial selection has meant that there is now increasing scrutiny on spectrophotometric and other non-invasive analytical techniques, some of which have been shown to provide adequate comparative analysis for oocyte quality and sperm DNA fragmentation rate. Whether this comparative analysis will be of clinical use, however, remains to be seen. | \nDavidson et al. [114] Sanchez et al. [115] | \n
In-vitro maturation (IVM) of immature oocytes | \nIVM aims to increase the yield of oocytes available for cryopreservation through the obtaintion of additional M2 oocytes from oocytes that would otherwise be discarded. Although data shows that approximately 35% of IVM oocytes can produce cleavage-stage embryos when fertilised, and this method has been suggested to increase the efficacy of treatment cycles aimed at fertility preservation, there is currently insufficient data to support the systematic use of IVM techniques or the freezing of immature oocytes. | \nOktay et al. [116] Phoon et al. [117] | \n
Selection via DNA fragmentation rate | \nIt is clear that a both vitrification and slow-freeze protocols produce DNA lesions, either via full or partial fragmentation. Although modern analytical techniques can quantify this fragmentation (and resulting apoptotic induction), they most commonly result in destruction of the gamete in question. As such, although they may provide valuable information on the quality of a particular sample, they do not provide a solution for the accurate selection of gametes which may prove more viable that their morphologically-normal counterparts. | \nValcarce et al. [118] | \n
CPA equilibration temperatures | \nChanging the equilibration temperature with CPA and increasing the sucrose concentration added have both proven to be effective strategies to improve oocyte survival and fertilisation rates, respectively | \nBorini et al. [119] | \n
Methods of improving gamete selection when employing cryopreservation techniques.
Although the technical aspects of gamete cryopreservation have been discussed at length above, one must also consider the societal and ethical impact of such procedures. Gametes are incredibly prized cells; holding the genetic information is required to produce related offspring for those at high risk of fertility disruption. Therefore, the conditions under which they are stored, the individuals permitted to handle them, access related information whilst they are stored, and the length of time which they can be stored for are of the utmost importance. Although legislative circumstances may vary from country to country, the HFEA permits storage of gametes or embryos for an initial maximum period of 10 years, with this being extended by 10 years at a time on a case-by-case basis up to a maximum of 55 years [61]. These limits are important to protect the wellbeing of prospective children, and to prevent the misuse of genetic material. Furthermore, as technological advances in genetics allow increasingly accurate prediction of phenotype and disease likelihood, it is likely that the genetic material contained within gametes will need progressively more stringent protection. An example of such measures includes the recently-enacted General Data Protection Regulation (GDPR), which legislates for the prevention of the misuse of such genetic data [62].
\nThe societal effects of the growing popularity of cryopreservation must also be considered. More women than ever before are experiencing the ironic dichotomy of spending the vast majority of their reproductive years trying no ensure that they do not fall pregnant, but then finding themselves unable to conceive when they try to. As such, the landscape of this exploding field is increasingly commercial, providing increased funds to facilitate advances in treatment efficacy at the cost of advertising cryopreservative services as an insurance policy against age-related fertility decline. There is also a worrying increase in the number of companies offering ‘social freezing’ as part of their employee benefit packages. This is a trend that propagates the misinformed idea that social cryopreservation guarantees a later pregnancy, and serves to perpetuate the societal pressure placed on women to delay childbearing [63]. The cost of such procedures (if not covered by insurance or a third party) is also a valid consideration, with various cost benefit analyses finding contrasting conclusions on whether it is more, or less cost-effective to cryopreserve in one’s mid-twenties and return to them at age 40, or just to attempt conventional IVF at age 40 [14, 64]. Whilst this is an important avenue of discussion, the superior success rates provided by the cryopreservation route are likely to provide a superior chance of obtaining a live birth.
\nWhile the risks associated with childbearing at an increased age may have the immediate downstream effects of reducing the incidence of certain genetic aberrations, it is also important to consider knock-on effects which may not be immediately obvious. It is possible that widespread societal gamete cryopreservation could unearth harmful novel ART-mediated epigenetic alterations, or further promote the delay of childbearing age. Such effects would doubtless affect the composition of our society, and the manner in which it functions. Therefore, the future direction and regulations governing this area must be scrutinised to determine what should, and should not be permitted. This is a more complex ethical discussion that falls outside of the scope of this chapter, but should nonetheless be kept in mind.
\n\n | Slow freezing | \nVitrification | \n
---|---|---|
Cleavage stage embryos | \n1.5 M PROH plus 0.1 M sucrose are included in the most commonly used protocols [74] | \nEG-based method was early proposed for vitrification of cleavage stage embryos [122] | \n
DMSO-based method initially reported the lowest survival rate [123] | \n||
EG/DMSO/sucrose in open or close systems are the most commonly used cryoprotectants | \n||
Blastocysts | \nGlycerol and sucrose as cryoprotectants are included in the most commonly used protocols [74] | \nEG and DMSO were the cryoprotectants used in the first pregnancy reported after blastocyst vitrification [124] | \n
EG/DMSO/sucrose in open or close system are also used [97, 125] | \n
Commonly used protocols for cryopreservation of cleavage stage human embryos and blastocysts.
Abbreviations: EG: ethylene glycol; DMSO: dimethylsulphoxide.
\n | Cleavage stage | \nBlastocyst stage | \n||
---|---|---|---|---|
\n | Day 2 | \nDay 3 | \nDay 5 | \nDay 6 | \n
Morphology before cryopreservation [74, 81, 97] | \n≥4 blastomeres | \n≥6 blastomeres | \nBlastocysts are scored according to expansion, inner mass and trophectoderm using Gardner scoring system – 3BB or better | \n|
<25% fragmentation | \n||||
No multinucleate blastomeres | \n||||
Morphology after thawing [74, 120] | \n≥50% intact blastomeres | \nScoring according to Gardner, as before cryopreservation | \n||
Higher number of blastomeres after 24 h of culture | \n||||
Expected survival [74, 121] | \n61.4–87.5% with slow freezing | \n76.3–88% with slow freezing | \n||
64–94% with vitrification | \n84–100% with vitrification | \n
Morphological aspects of embryos before/after cryopreservation and expected cryosurvival.
Since the early days of in vitro fertilisation (IVF) 40 years ago, there have been remarkable advances in clinical and laboratory areas that have opened the door to different variants of standard IVF procedure [65, 66]. Improvements of ovarian stimulation protocols enable the collection of several mature oocytes, which associated with the improvement of the IVF techniques and optimization of embryo culture result in the obtention of a large number of embryos. Therefore, embryo cryopreservation was a necessary evolutionary step for IVF-treatments with the first pregnancy after transfer of a frozen-thawed embryo being reported in 1984 [67]. Since then, embryo cryopreservation has become a widely used technic in assisted reproductive technology (ART), allowing the preservation of the remaining embryos following a fresh transfer for future pregnancies and as a modern tool to reduce multiple births by encouraging patients to transfer a single embryo [1, 68]. Additional indications for embryo cryopreservation are the embryo banking for preimplantation genetic screening, elective deferred embryo transfer, when the patient is at risk of a hyperstimulation and for fertility preservation [66, 69]. Thus, embryo cryopreservation greatly increased the safety and efficacy of IVF treatments and enable the later use of all the embryos obtained from a single oocyte pick-up.
\nOver the years, cryopreservation methods, protocols and stage at time of cryopreservation have changed, improving embryo cryopreservation techniques. Consequently, the number of frozen-thawed cycles increased worldwide [66, 70] with similar or even higher pregnancy rates compared with the transfer of fresh embryo [65, 70]. In Europe, the last report generated from registers by the European Society of Human Reproduction and Embryology (ESHRE) stated that 154,712 frozen-thawed cycles were performed in 2013, increasing the overall life birth rate by 6% [71].
\nHerein we will resume the evolution of the embryo cryopreservation methods, stage at which cryopreservation is performed and give an overview of the perinatal outcomes of frozen-thawed embryo transfers.
\nSince the first reports of pregnancy and delivery after transfer of frozen-thawed embryos in the earlies 1980s [67, 72] various protocols of embryo cryopreservation were introduced. They mostly differ from each other in the type and concentration of cryoprotectants, equilibration timing, cooling rates and freezing devices [35]. Regardless of the cryopreservation method used, the goal is to suspend embryos in time by cooling embryos from ambient temperature to −196°C [73]. Nowadays slow freezing and vitrification are the two principal approaches for embryo cryopreservation, although vitrification has become favored over the last decade [35, 74].
\nIn slow-freezing protocol the temperature is decreased sufficiently slowly to allow the adequate cellular dehydration but also minimising the formation of intracellular ice. This is only possible through the use of a programmable freezing machine. With this method, the samples are first exposed to a quick cooling rate of 2°C/minute until they reach −7°C. Then extracellular ice crystal formation is induced manually (seeding) by touching the vial or straw with precooled forceps as far away from the embryos as possible. As consequence, more water leaves the embryo allowing cryoprotectants to enter. After the seeding, the temperature decreases slowly (0.3–1°C/minute) untill it reaches temperatures approximately −40°C and then rapidly to −150°C with a cooling rate of approximately 50°C/minute. The embryos are then stored in liquid nitrogen until use [35, 74].
\nAlthough the first pregnancies and birth were obtain with an embryo cryopreserved with dimethylsulphoxide (DMSO) as cryoprotectant [67, 72] births using other cryoprotectants, such as propanediol (PrOH) were soon reported [75, 76]. Since then, this has become the cryoprotectant more widely used in combination with sucrose for embryo cryopreservation by slow-freezing [35] (Table 2). The disadvantage of the slow-freezing method is the formation of ice crystals, increasing the risk of cell damage during thawing. Therefore, despite this method has being used for over 30 years in IVF laboratories and considered safe, since the concentrations of the cryoprotectants used to avoid ice crystal formation are low, another technique was developed to improve embryo cryopreservation—the vitrification.
\nWith vitrification, the ice formation is almost eliminated since the cells and the extracellular milieu are solidified into a glass-like state [77]. This method has an extremely high cooling rate in the range of 2500–30,000°C/minute till −196°C by immediate exposure to liquid nitrogen [74, 77]. Despite the high concentrations of cryoprotectants that this method requires, its potential toxicity is reduced by the short time of exposure and the small volume of cryoprotectants used [35]. As in the slow-freezing method different cryoprotectants were tested, leading to the current preferred combination of DMSO (15%), ethylene glycol (EG-15%) and sucrose (0.5 M) in a minimum volume (≤1 μl) [78] (Table 2). The biggest difference between vitrification protocols relates to the cooling and storage methods employed, with open system, involving direct embryo contact with the liquid nitrogen, or closed system involving specific devices to avoid direct contact with the liquid nitrogen [35].
\nWith vitrification a laboratory can expect to obtain an increased embryo cryosurvival rate comparing to the slow-freezing method (Table 3), has well as a beneficial effect in the clinical pregnancy rate and live-birth rate per embryo transfer [35, 74, 79, 80]. Additionally, vitrification method does not require any specific equipment and is less time consuming compared to slow-freezing. Consequently, many laboratories worldwide have completely replaced slow-freezing with vitrification [35].
\nThe first pregnancy was obtained with an embryo cryopreserved at eight cells stage [67]. Since then the procedure has changed several times, with the current practice being to preserve either at the cleavage stage Day 2 or 3 of culture or at the stage of blastocyst at day 5 or 6 of culture, despite no clear evidence of which strategy is more beneficial for frozen-thawed embryo transfer [81, 82]. Since only few randomised controlled trials (RCTs) have been conducted to determine what stage of development optimises cumulative birth rate for the retrieval cycle, most of the available data about the timing of embryo cryopreservation is derived from outcomes of fresh cycles [73].
\nDespite the method of cryopreservation and embryo’s stage, the embryo selection for cryopreservation is based on their morphology and pre-freezing morphology is directly related with cryopreservation success and efficiency [83].
\nFor cleavage stage embryos, it is recommended that the embryos selected for cryopreservation should have 4 cells at day 2 and 8 cells at day 3, less than 10% of fragmentation, stage specific cell size and no multinucleate blastomeres [84] (Table 3). After thawing, embryos with 100% intact blastomeres will have a higher implantation. However, in embryos with 50% or more cells intact post-thaw and with mitotic resumption, the number the cells at the transfer may be more predictive of the embryo’s ability to implant than the percentage of cells surviving at the time of thawing [85, 86, 87]. These parameters remain the most clinically important criteria to evaluate the implantation rate potential till today [83].
\nAdvances in culture systems have made possible to prolong embryo culture until the embryo reaches the blastocyst stage. Thus, over the last decade blastocyst transfer at day 5/6 of culture has greatly increased and is seen for some as a “natural selection” of the most viable embryo, similar to the process during spontaneous conception [88, 89]. However, the clinical efficacy of blastocyst transfer over cleavage stage transfer is debatable. In fact, in 2016 a Cochrane meta-analysis reported an increase of clinical pregnancy and live birth after blastocyst transfer [82] but 1 year later another meta-analysis did not find any statistical difference in outcomes when comparing the transfer of embryos at the cleavage stage or blastocyst [90], the same results were previously described for cryopreserved embryos [81].
\nAs with cleavage stage embryos, assessment of blastocyst stage cryopreservation outcomes requires attention to variety of factors before cryopreservation and after thawing in addition to methodology. Outcomes have been shown to be dependent on pre-freeze quality of the blastocyst and time required to reach the blastocyst stage [91, 92].
\nThe most commonly used blastocyst grading systems assigns scores to three morphologic aspects of the embryo: quality of inner cell mass—grades A, B, C; quality of the trophectoderm—grades A, B, C and degree of expansion (Table 3). Blastocyst score at the time of cryopreservation was associated with survival and implantation rates [93, 94, 95]. Other factors that may contribute to outcomes are the day the cryopreserved embryo reached the blastocyst stage [5, 6], whether the blastocoel was collapsed or not prior to cryopreservation, and evidence of blastocoel re-expansion prior to transfer [96, 97].
\nFrozen-thawed cycles increased during the last decade and a concern about the perinatal outcome also have risen [66]. Although embryo cryopreservation is a well established procedure, long-term studies are still sparse [35]. Data are reassuring suggesting that pregnancies obtained from frozen embryos are not associated with an increased perinatal risk compared to fresh transfers [98, 99, 100, 101, 102, 103, 104]. Several reviews have indicated a slightly better result when frozen-thawed embryos were used compared to the fresh transfer, with reduced risks of preterm birth, small for gestational age babies, low birth weight babies and pre-eclampsia, which could be justified by the endocrine milieu of the stimulation when the transfer is made fresh [70, 99, 102, 104].
\nFurthermore, a systematic review, published recently, confirmed that singleton babies born after the transfer of frozen-thawed embryos have higher weight at birth when compared to babies born after the transfer of fresh embryos, as well as a higher risk of hypertensive disorders during pregnancy [70].
\nTo further improve IVF outcomes, it has been suggested to freeze all the embryos obtained in a stimulation cycle and then plan a deferred transfer during a natural cycle or with hormone replacement with exogenous estradiol (E2) and progesterone (P) for endometrial priming [105, 106]. With this strategy, the frozen-thawed embryos are transferred into a more “physiological milieu” which seems to improve implantation and outcomes compared to fresh transfer [106, 107, 108]. However, almost all the data was obtained in patients with high ovarian response patients and thus it was suggested that the freeze all strategy should be perform on patients with a risk of ovarian hyperstimulation syndrome (OHSS), since it was not clear if normal and poor responders will be the same benefits from freezing all the embryos [109].
\nA recent retrospective study using the general population has reported that 50.74% of patients using the freeze-all strategy achieved a live birth after the first complete cycle [105]. Additionally, another study indicated positive results in poor ovarian responders, and suggested the freeze-all strategy as an alternative to cycle cancellation for these patients [110]. Despite these positive results, large multi-centre randomised controlled trials are needed to evaluate the freeze-all strategy [105, 110].
\nIn conclusion, the cryopreservation of gametes and embryos is a rapidly developing field that demonstrates increasingly comparable success rates to those encountered in conventional IVF using fresh gametes or embryos. Aiming to provide reproductive autonomy for patients, it is intrinsically intertwined with both societal and ethical issues, and will doubtless play an increasingly central role in how we as a species reproduce over the coming decades. Research indicates also safety of reproductive treatments using cryopreserved gametes and embryos.
\nK. Rodriguez-Wallberg is supported by research grants from Stockholm County Council, Karolinska Institutet, The Swedish Cancer Society and Radiumhemmets’s Research Funds.
\nSupporting women in scientific research and encouraging more women to pursue careers in STEM fields has been an issue on the global agenda for many years. But there is still much to be done. And IntechOpen wants to help.
",metaTitle:"IntechOpen Women in Science Program",metaDescription:"Supporting women in scientific research and encouraging more women to pursue careers in STEM fields has been an issue on the global agenda for many years. But there is still much to be done. And IntechOpen wants to help.",metaKeywords:null,canonicalURL:null,contentRaw:'[{"type":"htmlEditorComponent","content":"At IntechOpen, we’re laying the foundations for the future by publishing the best research by women in STEM – Open Access and available to all. Our Women in Science program already includes six books in progress by award-winning women scientists on topics ranging from physics to robotics, medicine to environmental science. Our editors come from all over the globe and include L’Oreal–UNESCO For Women in Science award-winners and National Science Foundation and European Commission grant recipients.
\\n\\nWe aim to publish 100 books in our Women in Science program over the next three years. We are looking for books written, edited, or co-edited by women. Contributing chapters by men are welcome. As always, the quality of the research we publish is paramount.
\\n\\nAll project proposals go through a two-stage peer review process and are selected based on the following criteria:
\\n\\nPlus, we want this project to have an impact beyond scientific circles. We will publicize the research in the Women in Science program for a wider general audience through:
\\n\\nInterested? If you have an idea for an edited volume or a monograph, we’d love to hear from you! Contact Ana Pantar at book.idea@intechopen.com.
\\n\\n“My scientific path has given me the opportunity to work with colleagues all over Europe, including Germany, France, and Norway. Editing the book Graph Theory: Advanced Algorithms and Applications with IntechOpen emphasized for me the importance of providing valuable, Open Access literature to our scientific colleagues around the world. So I am highly enthusiastic about the Women in Science book collection, which will highlight the outstanding accomplishments of women scientists and encourage others to walk the challenging path to becoming a recognized scientist." Beril Sirmacek, TU Delft, The Netherlands
\\n\\nAdvantages of Publishing with IntechOpen
\\n\\n\\n"}]'},components:[{type:"htmlEditorComponent",content:'At IntechOpen, we’re laying the foundations for the future by publishing the best research by women in STEM – Open Access and available to all. Our Women in Science program already includes six books in progress by award-winning women scientists on topics ranging from physics to robotics, medicine to environmental science. Our editors come from all over the globe and include L’Oreal–UNESCO For Women in Science award-winners and National Science Foundation and European Commission grant recipients.
\n\nWe aim to publish 100 books in our Women in Science program over the next three years. We are looking for books written, edited, or co-edited by women. Contributing chapters by men are welcome. As always, the quality of the research we publish is paramount.
\n\nAll project proposals go through a two-stage peer review process and are selected based on the following criteria:
\n\nPlus, we want this project to have an impact beyond scientific circles. We will publicize the research in the Women in Science program for a wider general audience through:
\n\nInterested? If you have an idea for an edited volume or a monograph, we’d love to hear from you! Contact Ana Pantar at book.idea@intechopen.com.
\n\n“My scientific path has given me the opportunity to work with colleagues all over Europe, including Germany, France, and Norway. Editing the book Graph Theory: Advanced Algorithms and Applications with IntechOpen emphasized for me the importance of providing valuable, Open Access literature to our scientific colleagues around the world. So I am highly enthusiastic about the Women in Science book collection, which will highlight the outstanding accomplishments of women scientists and encourage others to walk the challenging path to becoming a recognized scientist." Beril Sirmacek, TU Delft, The Netherlands
\n\n\n\n\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{sort:"featured,name"},profiles:[{id:"289905",title:"Dr.",name:null,middleName:null,surname:"Inamuddin",slug:"inamuddin",fullName:"Inamuddin",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/289905/images/system/289905.jpeg",biography:"Dr. Inamuddin is currently working as an assistant professor in the Chemistry Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia. He has extensive research experience in multidisciplinary fields of analytical chemistry, materials chemistry, electrochemistry, and more specifically, renewable energy and the environment. He has published 127 research articles in international journals of repute and 18 book chapters in knowledge-based book editions published by renowned international publishers. He has published 39 edited books with Springer, United Kingdom, Elsevier, Nova Science Publishers, Inc. USA, CRC Press Taylor & Francis, Asia Pacific, Trans Tech Publications Ltd., Switzerland, and Materials Science Forum, USA. He is a member of various editorial boards serving as associate editor for journals such as Environmental Chemistry Letter, Applied Water Science, Euro-Mediterranean Journal for Environmental Integration, Springer-Nature, Scientific Reports-Nature, and the editor of Eurasian Journal of Analytical Chemistry.",institutionString:"King Abdulaziz University",institution:{name:"King Abdulaziz University",country:{name:"Saudi Arabia"}}},{id:"99002",title:"Dr.",name:null,middleName:null,surname:"Koontongkaew",slug:"koontongkaew",fullName:"Koontongkaew",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Thammasat University",country:{name:"Thailand"}}},{id:"156647",title:"Dr.",name:"A K M Mamunur",middleName:null,surname:"Rashid",slug:"a-k-m-mamunur-rashid",fullName:"A K M Mamunur Rashid",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:"MBBS, DCH, MD(Paed.), Grad. Cert. P. Rheum.(UWA, Australia), FRCP(Edin.)",institutionString:null,institution:{name:"Khulna Medical College",country:{name:"Bangladesh"}}},{id:"234696",title:"Prof.",name:"A K M Mominul",middleName:null,surname:"Islam",slug:"a-k-m-mominul-islam",fullName:"A K M Mominul Islam",position:null,profilePictureURL:"https://intech-files.s3.amazonaws.com/a043Y00000cA8dpQAC/Co2_Profile_Picture-1588761796759",biography:"Prof. Dr. A. K. M. Mominul Islam received both of his bachelor's and Master’s degree from Bangladesh Agricultural University. After that, he joined as Lecturer of Agronomy at Bangladesh Agricultural University (BAU), Mymensingh, Bangladesh, and became Professor in the same department of the university. Dr. Islam did his second Master’s in Physical Land Resources from Ghent University, Belgium. He is currently serving as a postdoctoral researcher at the Department of Horticulture & Landscape Architecture at Purdue University, USA. Dr. Islam has obtained his Ph.D. degree in Plant Allelopathy from The United Graduate School of Agricultural Sciences, Ehime University, Japan. The dissertation title of Dr. Islam was “Allelopathy of five Lamiaceae medicinal plant species”. Dr. Islam is the author of 38 articles published in nationally and internationally reputed journals, 1 book chapter, and 3 books. He is a member of the editorial board and referee of several national and international journals. He is supervising the research of MS and Ph.D. students in areas of Agronomy. Prof. Islam is conducting research on crop management, bio-herbicides, and allelopathy.",institutionString:"Bangladesh Agricultural University",institution:{name:"Bangladesh Agricultural University",country:{name:"Bangladesh"}}},{id:"214531",title:"Mr.",name:"A T M Sakiur",middleName:null,surname:"Rahman",slug:"a-t-m-sakiur-rahman",fullName:"A T M Sakiur Rahman",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Rajshahi",country:{name:"Bangladesh"}}},{id:"66545",title:"Dr.",name:"A. F.",middleName:null,surname:"Omar",slug:"a.-f.-omar",fullName:"A. F. Omar",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:"Dr. A. F. Omar obtained\nhis Bachelor degree in electrical and\nelectronics engineering from Universiti\nSains Malaysia in 2002, Master of Science in electronics\nengineering from Open University\nMalaysia in 2008 and PhD in optical physics from Universiti\nSains Malaysia in 2012. His research mainly\nfocuses on the development of optical\nand electronics systems for spectroscopy\napplication in environmental monitoring,\nagriculture and dermatology. He has\nmore than 10 years of teaching\nexperience in subjects related to\nelectronics, mathematics and applied optics for\nuniversity students and industrial engineers.",institutionString:null,institution:{name:"Universiti Sains Malaysia",country:{name:"Malaysia"}}},{id:"191072",title:"Prof.",name:"A. K. M. Aminul",middleName:null,surname:"Islam",slug:"a.-k.-m.-aminul-islam",fullName:"A. K. M. Aminul Islam",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/191072/images/system/191072.jpg",biography:"Prof. Dr. A. K. M. Aminul Islam received both of his bachelor and Master’s degree from Bangladesh Agricultural University. After that he joined as Lecturer of Genetics and Plant Breeding at Bangabandhu Sheikh Mujibur Rahman Agricultural University (BSMRAU), Gazipur, Bangladesh and became Professor in the same department of the university. He is currently serving as Director (Research) of Bangabandhu Sheikh Mujibur Rahman Agricultural University (BSMRAU), Gazipur, Bangladesh. Dr. Islam has obtained his Ph D degree in Chemical and Process Engineering from Universiti Kebangsaan Malaysia. The dissertation title of Dr. Islam was “Improvement of Biodiesel Production through Genetic Studies of Jatropha (Jatropha curcas L.)”. Dr. Islam is the author of 98 articles published in nationally and internationally reputed journals, 11 book chapters and 3 books. He is a member of editorial board and referee of several national and international journals. He is also serving as the General Secretary of Plant Breeding and Genetics Society of Bangladesh, Seminar and research Secretary of JICA Alumni Association of Bangladesh and member of several professional societies. Prof. Islam acted as Principal Breeder in the releasing system of BU Hybrid Lau 1, BU Lau 1, BU Capsicum 1, BU Lalshak 1, BU Baromashi Seem 1, BU Sheem 1, BU Sheem 2, BU Sheem 3 and BU Sheem 4. He supervised 50 MS and 3 Ph D students. Prof. Islam currently supervising research of 5 MS and 3 Ph D students in areas Plant Breeding & Seed Technologies. Conducting research on development of hybrid vegetables, hybrid Brassica napus using CMS system, renewable energy research with Jatropha curcas.",institutionString:"Bangabandhu Sheikh Mujibur Rahman Agricultural University",institution:{name:"Bangabandhu Sheikh Mujibur Rahman Agricultural University",country:{name:"Bangladesh"}}},{id:"322225",title:"Dr.",name:"A. K. M. Aminul",middleName:null,surname:"Islam",slug:"a.-k.-m.-aminul-islam",fullName:"A. K. M. Aminul Islam",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/no_image.jpg",biography:"Prof. Dr. A. K. M. Aminul Islam received both of his bachelor's and Master’s degree from Bangladesh Agricultural University. After that he joined as Lecturer of Genetics and Plant Breeding at Bangabandhu Sheikh Mujibur Rahman Agricultural University (BSMRAU), Gazipur, Bangladesh, and became Professor in the same department of the university. He is currently serving as Director (Research) of Bangabandhu Sheikh Mujibur Rahman Agricultural University (BSMRAU), Gazipur, Bangladesh. Dr. Islam has obtained his Ph.D. degree in Chemical and Process Engineering from Universiti Kebangsaan Malaysia. The dissertation title of Dr. Islam was 'Improvement of Biodiesel Production through Genetic Studies of Jatropha (Jatropha curcas L.)”. Dr. Islam is the author of 99 articles published in nationally and internationally reputed journals, 11 book chapters, 3 books, and 20 proceedings and conference paper. He is a member of the editorial board and referee of several national and international journals. He is also serving as the General Secretary of Plant Breeding and Genetics Society of Bangladesh, Seminar, and research Secretary of JICA Alumni Association of Bangladesh and a member of several professional societies. Prof. Islam acted as Principal Breeder in the releasing system of BU Hybrid Lau 1, BU Lau 1, BU Capsicum 1, BU Lalshak 1, BU Baromashi Seem 1, BU Sheem 1, BU Sheem 2, BU Sheem 3 and BU Sheem 4. He supervised 50 MS and 3 PhD students. Prof. Islam currently supervising the research of 5 MS and 3 PhD students in areas Plant Breeding & Seed Technologies. Conducting research on the development of hybrid vegetables, hybrid Brassica napus using CMS system, renewable energy research with Jatropha curcas.",institutionString:"Bangabandhu Sheikh Mujibur Rahman Agricultural University",institution:{name:"Bangabandhu Sheikh Mujibur Rahman Agricultural University",country:{name:"Bangladesh"}}},{id:"91977",title:"Dr.",name:"A.B.M. Sharif",middleName:null,surname:"Hossain",slug:"a.b.m.-sharif-hossain",fullName:"A.B.M. Sharif Hossain",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Malaya",country:{name:"Malaysia"}}},{id:"97123",title:"Prof.",name:"A.M.M.",middleName:null,surname:"Sharif Ullah",slug:"a.m.m.-sharif-ullah",fullName:"A.M.M. Sharif Ullah",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/97123/images/4209_n.jpg",biography:"AMM Sharif Ullah is currently an Associate Professor of Design and Manufacturing in Department of Mechanical Engineering at Kitami Institute of Technology, Japan. He received the Bachelor of Science Degree in Mechanical Engineering in 1992 from the Bangladesh University of Engineering and Technology, Dhaka, Bangladesh. In 1993, he moved to Japan for graduate studies. He received the Master of Engineering degree in 1996 from the Kansai University Graduate School of Engineering in Mechanical Engineering (Major: Manufacturing Engineering). He also received the Doctor of Engineering degree from the same institute in the same field in 1999. He began his academic career in 2000 as an Assistant Professor in the Industrial Systems Engineering Program at the Asian Institute of Technology, Thailand, as an Assistant Professor in the Industrial Systems Engineering Program. In 2002, he took up the position of Assistant Professor in the Department of Mechanical Engineering at the United Arab Emirates (UAE) University. He was promoted to Associate Professor in 2006 at the UAE University. He moved to his current employer in 2009. His research field is product realization engineering (design, manufacturing, operations, and sustainability). He teaches design and manufacturing related courses at undergraduate and graduate degree programs. He has been mentoring a large number of students for their senior design projects and theses. He has published more than 90 papers in refereed journals, edited books, and international conference proceedings. He made more than 35 oral presentations. Since 2005, he directs the advanced manufacturing engineering research laboratory at Kitami Institute of Technology.",institutionString:null,institution:{name:"Kitami Institute of Technology",country:{name:"Japan"}}},{id:"213441",title:"Dr.",name:"A.R.Kavitha",middleName:null,surname:"Balaji",slug:"a.r.kavitha-balaji",fullName:"A.R.Kavitha Balaji",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Anna University, Chennai",country:{name:"India"}}},{id:"172688",title:"Prof.",name:"A.V.",middleName:null,surname:"Salker",slug:"a.v.-salker",fullName:"A.V. Salker",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Goa University",country:{name:"India"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:5684},{group:"region",caption:"Middle and South America",value:2,count:5166},{group:"region",caption:"Africa",value:3,count:1682},{group:"region",caption:"Asia",value:4,count:10211},{group:"region",caption:"Australia and Oceania",value:5,count:887},{group:"region",caption:"Europe",value:6,count:15616}],offset:12,limit:12,total:10241},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{topicId:"20"},books:[{type:"book",id:"10206",title:"Terahertz Technology",subtitle:null,isOpenForSubmission:!0,hash:"2cdb79bf6297623f1d6202ef11f099c4",slug:null,bookSignature:"Dr. Borwen You and Dr. Ja-Yu Lu",coverURL:"https://cdn.intechopen.com/books/images_new/10206.jpg",editedByType:null,editors:[{id:"191131",title:"Dr.",name:"Borwen",surname:"You",slug:"borwen-you",fullName:"Borwen You"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10575",title:"Magnetic Skyrmions",subtitle:null,isOpenForSubmission:!0,hash:"d93d7485e8a6a30d9e069aed78fdb355",slug:null,bookSignature:"Prof. Dipti Ranjan Sahu",coverURL:"https://cdn.intechopen.com/books/images_new/10575.jpg",editedByType:null,editors:[{id:"251855",title:"Prof.",name:"Dipti Ranjan",surname:"Sahu",slug:"dipti-ranjan-sahu",fullName:"Dipti Ranjan Sahu"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10675",title:"Hydrostatics",subtitle:null,isOpenForSubmission:!0,hash:"c86c2fa9f835d4ad5e7efd8b01921866",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10675.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10957",title:"Liquid Crystals",subtitle:null,isOpenForSubmission:!0,hash:"b8dac1788dc54d12f8fc3d94a7e3e338",slug:null,bookSignature:"",coverURL:"//cdnintech.com/web/frontend/www/assets/cover.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:9},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:18},{group:"topic",caption:"Business, Management and Economics",value:7,count:2},{group:"topic",caption:"Chemistry",value:8,count:7},{group:"topic",caption:"Computer and Information Science",value:9,count:10},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:5},{group:"topic",caption:"Engineering",value:11,count:14},{group:"topic",caption:"Environmental Sciences",value:12,count:2},{group:"topic",caption:"Immunology and Microbiology",value:13,count:5},{group:"topic",caption:"Materials Science",value:14,count:4},{group:"topic",caption:"Mathematics",value:15,count:1},{group:"topic",caption:"Medicine",value:16,count:60},{group:"topic",caption:"Nanotechnology and Nanomaterials",value:17,count:1},{group:"topic",caption:"Neuroscience",value:18,count:1},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:6},{group:"topic",caption:"Physics",value:20,count:2},{group:"topic",caption:"Psychology",value:21,count:3},{group:"topic",caption:"Robotics",value:22,count:1},{group:"topic",caption:"Social Sciences",value:23,count:3},{group:"topic",caption:"Technology",value:24,count:1},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:2}],offset:12,limit:12,total:4},popularBooks:{featuredBooks:[{type:"book",id:"9208",title:"Welding",subtitle:"Modern Topics",isOpenForSubmission:!1,hash:"7d6be076ccf3a3f8bd2ca52d86d4506b",slug:"welding-modern-topics",bookSignature:"Sadek Crisóstomo Absi Alfaro, Wojciech Borek and Błażej Tomiczek",coverURL:"https://cdn.intechopen.com/books/images_new/9208.jpg",editors:[{id:"65292",title:"Prof.",name:"Sadek Crisostomo Absi",middleName:"C. Absi",surname:"Alfaro",slug:"sadek-crisostomo-absi-alfaro",fullName:"Sadek Crisostomo Absi Alfaro"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9139",title:"Topics in Primary Care Medicine",subtitle:null,isOpenForSubmission:!1,hash:"ea774a4d4c1179da92a782e0ae9cde92",slug:"topics-in-primary-care-medicine",bookSignature:"Thomas F. Heston",coverURL:"https://cdn.intechopen.com/books/images_new/9139.jpg",editors:[{id:"217926",title:"Dr.",name:"Thomas F.",middleName:null,surname:"Heston",slug:"thomas-f.-heston",fullName:"Thomas F. Heston"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8697",title:"Virtual Reality and Its Application in Education",subtitle:null,isOpenForSubmission:!1,hash:"ee01b5e387ba0062c6b0d1e9227bda05",slug:"virtual-reality-and-its-application-in-education",bookSignature:"Dragan Cvetković",coverURL:"https://cdn.intechopen.com/books/images_new/8697.jpg",editors:[{id:"101330",title:"Dr.",name:"Dragan",middleName:"Mladen",surname:"Cvetković",slug:"dragan-cvetkovic",fullName:"Dragan Cvetković"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9785",title:"Endometriosis",subtitle:null,isOpenForSubmission:!1,hash:"f457ca61f29cf7e8bc191732c50bb0ce",slug:"endometriosis",bookSignature:"Courtney Marsh",coverURL:"https://cdn.intechopen.com/books/images_new/9785.jpg",editors:[{id:"255491",title:"Dr.",name:"Courtney",middleName:null,surname:"Marsh",slug:"courtney-marsh",fullName:"Courtney Marsh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9343",title:"Trace Metals in the Environment",subtitle:"New Approaches and Recent Advances",isOpenForSubmission:!1,hash:"ae07e345bc2ce1ebbda9f70c5cd12141",slug:"trace-metals-in-the-environment-new-approaches-and-recent-advances",bookSignature:"Mario Alfonso Murillo-Tovar, Hugo Saldarriaga-Noreña and Agnieszka Saeid",coverURL:"https://cdn.intechopen.com/books/images_new/9343.jpg",editors:[{id:"255959",title:"Dr.",name:"Mario Alfonso",middleName:null,surname:"Murillo-Tovar",slug:"mario-alfonso-murillo-tovar",fullName:"Mario Alfonso Murillo-Tovar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7831",title:"Sustainability in Urban Planning and Design",subtitle:null,isOpenForSubmission:!1,hash:"c924420492c8c2c9751e178d025f4066",slug:"sustainability-in-urban-planning-and-design",bookSignature:"Amjad Almusaed, Asaad Almssad and Linh Truong - Hong",coverURL:"https://cdn.intechopen.com/books/images_new/7831.jpg",editors:[{id:"110471",title:"Dr.",name:"Amjad",middleName:"Zaki",surname:"Almusaed",slug:"amjad-almusaed",fullName:"Amjad Almusaed"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8468",title:"Sheep Farming",subtitle:"An Approach to Feed, Growth and Sanity",isOpenForSubmission:!1,hash:"838f08594850bc04aa14ec873ed1b96f",slug:"sheep-farming-an-approach-to-feed-growth-and-sanity",bookSignature:"António Monteiro",coverURL:"https://cdn.intechopen.com/books/images_new/8468.jpg",editors:[{id:"190314",title:"Prof.",name:"António",middleName:"Cardoso",surname:"Monteiro",slug:"antonio-monteiro",fullName:"António Monteiro"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8816",title:"Financial Crises",subtitle:"A Selection of Readings",isOpenForSubmission:!1,hash:"6f2f49fb903656e4e54280c79fabd10c",slug:"financial-crises-a-selection-of-readings",bookSignature:"Stelios Markoulis",coverURL:"https://cdn.intechopen.com/books/images_new/8816.jpg",editors:[{id:"237863",title:"Dr.",name:"Stelios",middleName:null,surname:"Markoulis",slug:"stelios-markoulis",fullName:"Stelios Markoulis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9376",title:"Contemporary Developments and Perspectives in International Health Security",subtitle:"Volume 1",isOpenForSubmission:!1,hash:"b9a00b84cd04aae458fb1d6c65795601",slug:"contemporary-developments-and-perspectives-in-international-health-security-volume-1",bookSignature:"Stanislaw P. Stawicki, Michael S. Firstenberg, Sagar C. Galwankar, Ricardo Izurieta and Thomas Papadimos",coverURL:"https://cdn.intechopen.com/books/images_new/9376.jpg",editors:[{id:"181694",title:"Dr.",name:"Stanislaw P.",middleName:null,surname:"Stawicki",slug:"stanislaw-p.-stawicki",fullName:"Stanislaw P. Stawicki"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7769",title:"Medical Isotopes",subtitle:null,isOpenForSubmission:!1,hash:"f8d3c5a6c9a42398e56b4e82264753f7",slug:"medical-isotopes",bookSignature:"Syed Ali Raza Naqvi and Muhammad Babar Imrani",coverURL:"https://cdn.intechopen.com/books/images_new/7769.jpg",editors:[{id:"259190",title:"Dr.",name:"Syed Ali Raza",middleName:null,surname:"Naqvi",slug:"syed-ali-raza-naqvi",fullName:"Syed Ali Raza Naqvi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9279",title:"Concepts, Applications and Emerging Opportunities in Industrial Engineering",subtitle:null,isOpenForSubmission:!1,hash:"9bfa87f9b627a5468b7c1e30b0eea07a",slug:"concepts-applications-and-emerging-opportunities-in-industrial-engineering",bookSignature:"Gary Moynihan",coverURL:"https://cdn.intechopen.com/books/images_new/9279.jpg",editors:[{id:"16974",title:"Dr.",name:"Gary",middleName:null,surname:"Moynihan",slug:"gary-moynihan",fullName:"Gary Moynihan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7807",title:"A Closer Look at Organizational Culture in Action",subtitle:null,isOpenForSubmission:!1,hash:"05c608b9271cc2bc711f4b28748b247b",slug:"a-closer-look-at-organizational-culture-in-action",bookSignature:"Süleyman Davut Göker",coverURL:"https://cdn.intechopen.com/books/images_new/7807.jpg",editors:[{id:"190035",title:"Associate Prof.",name:"Süleyman Davut",middleName:null,surname:"Göker",slug:"suleyman-davut-goker",fullName:"Süleyman Davut Göker"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:5131},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"9208",title:"Welding",subtitle:"Modern Topics",isOpenForSubmission:!1,hash:"7d6be076ccf3a3f8bd2ca52d86d4506b",slug:"welding-modern-topics",bookSignature:"Sadek Crisóstomo Absi Alfaro, Wojciech Borek and Błażej Tomiczek",coverURL:"https://cdn.intechopen.com/books/images_new/9208.jpg",editors:[{id:"65292",title:"Prof.",name:"Sadek Crisostomo Absi",middleName:"C. Absi",surname:"Alfaro",slug:"sadek-crisostomo-absi-alfaro",fullName:"Sadek Crisostomo Absi Alfaro"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9139",title:"Topics in Primary Care Medicine",subtitle:null,isOpenForSubmission:!1,hash:"ea774a4d4c1179da92a782e0ae9cde92",slug:"topics-in-primary-care-medicine",bookSignature:"Thomas F. Heston",coverURL:"https://cdn.intechopen.com/books/images_new/9139.jpg",editors:[{id:"217926",title:"Dr.",name:"Thomas F.",middleName:null,surname:"Heston",slug:"thomas-f.-heston",fullName:"Thomas F. Heston"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8697",title:"Virtual Reality and Its Application in Education",subtitle:null,isOpenForSubmission:!1,hash:"ee01b5e387ba0062c6b0d1e9227bda05",slug:"virtual-reality-and-its-application-in-education",bookSignature:"Dragan Cvetković",coverURL:"https://cdn.intechopen.com/books/images_new/8697.jpg",editors:[{id:"101330",title:"Dr.",name:"Dragan",middleName:"Mladen",surname:"Cvetković",slug:"dragan-cvetkovic",fullName:"Dragan Cvetković"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9785",title:"Endometriosis",subtitle:null,isOpenForSubmission:!1,hash:"f457ca61f29cf7e8bc191732c50bb0ce",slug:"endometriosis",bookSignature:"Courtney Marsh",coverURL:"https://cdn.intechopen.com/books/images_new/9785.jpg",editors:[{id:"255491",title:"Dr.",name:"Courtney",middleName:null,surname:"Marsh",slug:"courtney-marsh",fullName:"Courtney Marsh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9343",title:"Trace Metals in the Environment",subtitle:"New Approaches and Recent Advances",isOpenForSubmission:!1,hash:"ae07e345bc2ce1ebbda9f70c5cd12141",slug:"trace-metals-in-the-environment-new-approaches-and-recent-advances",bookSignature:"Mario Alfonso Murillo-Tovar, Hugo Saldarriaga-Noreña and Agnieszka Saeid",coverURL:"https://cdn.intechopen.com/books/images_new/9343.jpg",editors:[{id:"255959",title:"Dr.",name:"Mario Alfonso",middleName:null,surname:"Murillo-Tovar",slug:"mario-alfonso-murillo-tovar",fullName:"Mario Alfonso Murillo-Tovar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8468",title:"Sheep Farming",subtitle:"An Approach to Feed, Growth and Sanity",isOpenForSubmission:!1,hash:"838f08594850bc04aa14ec873ed1b96f",slug:"sheep-farming-an-approach-to-feed-growth-and-sanity",bookSignature:"António Monteiro",coverURL:"https://cdn.intechopen.com/books/images_new/8468.jpg",editors:[{id:"190314",title:"Prof.",name:"António",middleName:"Cardoso",surname:"Monteiro",slug:"antonio-monteiro",fullName:"António Monteiro"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8816",title:"Financial Crises",subtitle:"A Selection of Readings",isOpenForSubmission:!1,hash:"6f2f49fb903656e4e54280c79fabd10c",slug:"financial-crises-a-selection-of-readings",bookSignature:"Stelios Markoulis",coverURL:"https://cdn.intechopen.com/books/images_new/8816.jpg",editors:[{id:"237863",title:"Dr.",name:"Stelios",middleName:null,surname:"Markoulis",slug:"stelios-markoulis",fullName:"Stelios Markoulis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7831",title:"Sustainability in Urban Planning and Design",subtitle:null,isOpenForSubmission:!1,hash:"c924420492c8c2c9751e178d025f4066",slug:"sustainability-in-urban-planning-and-design",bookSignature:"Amjad Almusaed, Asaad Almssad and Linh Truong - Hong",coverURL:"https://cdn.intechopen.com/books/images_new/7831.jpg",editors:[{id:"110471",title:"Dr.",name:"Amjad",middleName:"Zaki",surname:"Almusaed",slug:"amjad-almusaed",fullName:"Amjad Almusaed"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9376",title:"Contemporary Developments and Perspectives in International Health Security",subtitle:"Volume 1",isOpenForSubmission:!1,hash:"b9a00b84cd04aae458fb1d6c65795601",slug:"contemporary-developments-and-perspectives-in-international-health-security-volume-1",bookSignature:"Stanislaw P. Stawicki, Michael S. Firstenberg, Sagar C. Galwankar, Ricardo Izurieta and Thomas Papadimos",coverURL:"https://cdn.intechopen.com/books/images_new/9376.jpg",editors:[{id:"181694",title:"Dr.",name:"Stanislaw P.",middleName:null,surname:"Stawicki",slug:"stanislaw-p.-stawicki",fullName:"Stanislaw P. Stawicki"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7769",title:"Medical Isotopes",subtitle:null,isOpenForSubmission:!1,hash:"f8d3c5a6c9a42398e56b4e82264753f7",slug:"medical-isotopes",bookSignature:"Syed Ali Raza Naqvi and Muhammad Babar Imrani",coverURL:"https://cdn.intechopen.com/books/images_new/7769.jpg",editors:[{id:"259190",title:"Dr.",name:"Syed Ali Raza",middleName:null,surname:"Naqvi",slug:"syed-ali-raza-naqvi",fullName:"Syed Ali Raza Naqvi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"7434",title:"Molecular Biotechnology",subtitle:null,isOpenForSubmission:!1,hash:"eceede809920e1ec7ecadd4691ede2ec",slug:"molecular-biotechnology",bookSignature:"Sergey Sedykh",coverURL:"https://cdn.intechopen.com/books/images_new/7434.jpg",editedByType:"Edited by",editors:[{id:"178316",title:"Ph.D.",name:"Sergey",middleName:null,surname:"Sedykh",slug:"sergey-sedykh",fullName:"Sergey Sedykh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8545",title:"Animal Reproduction in Veterinary Medicine",subtitle:null,isOpenForSubmission:!1,hash:"13aaddf5fdbbc78387e77a7da2388bf6",slug:"animal-reproduction-in-veterinary-medicine",bookSignature:"Faruk Aral, Rita Payan-Carreira and Miguel Quaresma",coverURL:"https://cdn.intechopen.com/books/images_new/8545.jpg",editedByType:"Edited by",editors:[{id:"25600",title:"Prof.",name:"Faruk",middleName:null,surname:"Aral",slug:"faruk-aral",fullName:"Faruk Aral"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9569",title:"Methods in Molecular Medicine",subtitle:null,isOpenForSubmission:!1,hash:"691d3f3c4ac25a8093414e9b270d2843",slug:"methods-in-molecular-medicine",bookSignature:"Yusuf Tutar",coverURL:"https://cdn.intechopen.com/books/images_new/9569.jpg",editedByType:"Edited by",editors:[{id:"158492",title:"Prof.",name:"Yusuf",middleName:null,surname:"Tutar",slug:"yusuf-tutar",fullName:"Yusuf Tutar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9839",title:"Outdoor Recreation",subtitle:"Physiological and Psychological Effects on Health",isOpenForSubmission:!1,hash:"5f5a0d64267e32567daffa5b0c6a6972",slug:"outdoor-recreation-physiological-and-psychological-effects-on-health",bookSignature:"Hilde G. Nielsen",coverURL:"https://cdn.intechopen.com/books/images_new/9839.jpg",editedByType:"Edited by",editors:[{id:"158692",title:"Ph.D.",name:"Hilde G.",middleName:null,surname:"Nielsen",slug:"hilde-g.-nielsen",fullName:"Hilde G. Nielsen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7802",title:"Modern Slavery and Human Trafficking",subtitle:null,isOpenForSubmission:!1,hash:"587a0b7fb765f31cc98de33c6c07c2e0",slug:"modern-slavery-and-human-trafficking",bookSignature:"Jane Reeves",coverURL:"https://cdn.intechopen.com/books/images_new/7802.jpg",editedByType:"Edited by",editors:[{id:"211328",title:"Prof.",name:"Jane",middleName:null,surname:"Reeves",slug:"jane-reeves",fullName:"Jane Reeves"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8063",title:"Food Security in Africa",subtitle:null,isOpenForSubmission:!1,hash:"8cbf3d662b104d19db2efc9d59249efc",slug:"food-security-in-africa",bookSignature:"Barakat Mahmoud",coverURL:"https://cdn.intechopen.com/books/images_new/8063.jpg",editedByType:"Edited by",editors:[{id:"92016",title:"Dr.",name:"Barakat",middleName:null,surname:"Mahmoud",slug:"barakat-mahmoud",fullName:"Barakat Mahmoud"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10118",title:"Plant Stress Physiology",subtitle:null,isOpenForSubmission:!1,hash:"c68b09d2d2634fc719ae3b9a64a27839",slug:"plant-stress-physiology",bookSignature:"Akbar Hossain",coverURL:"https://cdn.intechopen.com/books/images_new/10118.jpg",editedByType:"Edited by",editors:[{id:"280755",title:"Dr.",name:"Akbar",middleName:null,surname:"Hossain",slug:"akbar-hossain",fullName:"Akbar Hossain"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9157",title:"Neurodegenerative Diseases",subtitle:"Molecular Mechanisms and Current Therapeutic Approaches",isOpenForSubmission:!1,hash:"bc8be577966ef88735677d7e1e92ed28",slug:"neurodegenerative-diseases-molecular-mechanisms-and-current-therapeutic-approaches",bookSignature:"Nagehan Ersoy Tunalı",coverURL:"https://cdn.intechopen.com/books/images_new/9157.jpg",editedByType:"Edited by",editors:[{id:"82778",title:"Ph.D.",name:"Nagehan",middleName:null,surname:"Ersoy Tunalı",slug:"nagehan-ersoy-tunali",fullName:"Nagehan Ersoy Tunalı"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9961",title:"Data Mining",subtitle:"Methods, Applications and Systems",isOpenForSubmission:!1,hash:"ed79fb6364f2caf464079f94a0387146",slug:"data-mining-methods-applications-and-systems",bookSignature:"Derya Birant",coverURL:"https://cdn.intechopen.com/books/images_new/9961.jpg",editedByType:"Edited by",editors:[{id:"15609",title:"Dr.",name:"Derya",middleName:null,surname:"Birant",slug:"derya-birant",fullName:"Derya Birant"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8686",title:"Direct Torque Control Strategies of Electrical Machines",subtitle:null,isOpenForSubmission:!1,hash:"b6ad22b14db2b8450228545d3d4f6b1a",slug:"direct-torque-control-strategies-of-electrical-machines",bookSignature:"Fatma Ben Salem",coverURL:"https://cdn.intechopen.com/books/images_new/8686.jpg",editedByType:"Edited by",editors:[{id:"295623",title:"Associate Prof.",name:"Fatma",middleName:null,surname:"Ben Salem",slug:"fatma-ben-salem",fullName:"Fatma Ben Salem"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"814",title:"Fluid Dynamics",slug:"mechanical-engineering-fluid-dynamics",parent:{title:"Mechanical Engineering",slug:"mechanical-engineering"},numberOfBooks:8,numberOfAuthorsAndEditors:255,numberOfWosCitations:211,numberOfCrossrefCitations:95,numberOfDimensionsCitations:244,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicSlug:"mechanical-engineering-fluid-dynamics",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"4690",title:"Mass Transfer",subtitle:"Advancement in Process Modelling",isOpenForSubmission:!1,hash:"6a48c13966c5b7c9ecf0af315f87048b",slug:"mass-transfer-advancement-in-process-modelling",bookSignature:"Marek Solecki",coverURL:"https://cdn.intechopen.com/books/images_new/4690.jpg",editedByType:"Edited by",editors:[{id:"43535",title:"Dr.",name:"Marek",middleName:null,surname:"Solecki",slug:"marek-solecki",fullName:"Marek Solecki"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1659",title:"The Particle Image Velocimetry",subtitle:"Characteristics, Limits and Possible Applications",isOpenForSubmission:!1,hash:"64321309762b4a1b34529238e32ac638",slug:"the-particle-image-velocimetry-characteristics-limits-and-possible-applications",bookSignature:"Giovanna Cavazzini",coverURL:"https://cdn.intechopen.com/books/images_new/1659.jpg",editedByType:"Edited by",editors:[{id:"111606",title:"PhD.",name:"Giovanna",middleName:null,surname:"Cavazzini",slug:"giovanna-cavazzini",fullName:"Giovanna Cavazzini"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"615",title:"Advanced Methods for Practical Applications in Fluid Mechanics",subtitle:null,isOpenForSubmission:!1,hash:"779d768a546af1ba3f0aa171d0c5a9ee",slug:"advanced-methods-for-practical-applications-in-fluid-mechanics",bookSignature:"Steven A. Jones",coverURL:"https://cdn.intechopen.com/books/images_new/615.jpg",editedByType:"Edited by",editors:[{id:"64477",title:"Dr.",name:"Steven",middleName:"A.",surname:"Jones",slug:"steven-jones",fullName:"Steven Jones"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1955",title:"Hydrodynamics",subtitle:"Advanced Topics",isOpenForSubmission:!1,hash:"a2f5fb60944543c693da3c7aa4f07dae",slug:"hydrodynamics-advanced-topics",bookSignature:"Harry Edmar Schulz, André Luiz Andrade Simões and Raquel Jahara Lobosco",coverURL:"https://cdn.intechopen.com/books/images_new/1955.jpg",editedByType:"Edited by",editors:[{id:"20241",title:"Prof.",name:"Harry",middleName:"Edmar",surname:"Schulz",slug:"harry-schulz",fullName:"Harry Schulz"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1954",title:"Hydrodynamics",subtitle:"Optimizing Methods and Tools",isOpenForSubmission:!1,hash:"502818cd3f53e68a788a01c693a29e5d",slug:"hydrodynamics-optimizing-methods-and-tools",bookSignature:"Harry Edmar Schulz, André Luiz Andrade Simões and Raquel Jahara Lobosco",coverURL:"https://cdn.intechopen.com/books/images_new/1954.jpg",editedByType:"Edited by",editors:[{id:"20241",title:"Prof.",name:"Harry",middleName:"Edmar",surname:"Schulz",slug:"harry-schulz",fullName:"Harry Schulz"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"530",title:"Convection and Conduction Heat Transfer",subtitle:null,isOpenForSubmission:!1,hash:"d7473a9763ff4ee9a4f8bb5a1ba9cd5e",slug:"convection-and-conduction-heat-transfer",bookSignature:"Amimul Ahsan",coverURL:"https://cdn.intechopen.com/books/images_new/530.jpg",editedByType:"Edited by",editors:[{id:"36782",title:"Associate Prof.",name:"Amimul",middleName:null,surname:"Ahsan",slug:"amimul-ahsan",fullName:"Amimul Ahsan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"924",title:"Heat and Mass Transfer",subtitle:"Modeling and Simulation",isOpenForSubmission:!1,hash:"671686ebedf504b399b01e0a9f8ecfd3",slug:"heat-and-mass-transfer-modeling-and-simulation",bookSignature:"Monwar Hossain",coverURL:"https://cdn.intechopen.com/books/images_new/924.jpg",editedByType:"Edited by",editors:[{id:"18207",title:"Prof.",name:"Md Monwar",middleName:null,surname:"Hossain",slug:"md-monwar-hossain",fullName:"Md Monwar Hossain"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"228",title:"Waves in Fluids and Solids",subtitle:null,isOpenForSubmission:!1,hash:"91a31715c4cb38a9c947a519163c45fc",slug:"waves-in-fluids-and-solids",bookSignature:"Ruben Pico Vila",coverURL:"https://cdn.intechopen.com/books/images_new/228.jpg",editedByType:"Edited by",editors:[{id:"49934",title:"Prof.",name:"Ruben",middleName:null,surname:"Pico Vila",slug:"ruben-pico-vila",fullName:"Ruben Pico Vila"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:8,mostCitedChapters:[{id:"22262",doi:"10.5772/19836",title:"Modelling of Heat Transfer and Phase Transformations in the Rapid Manufacturing of Titanium Components",slug:"modelling-of-heat-transfer-and-phase-transformations-in-the-rapid-manufacturing-of-titanium-componen",totalDownloads:2717,totalCrossrefCites:5,totalDimensionsCites:16,book:{slug:"convection-and-conduction-heat-transfer",title:"Convection and Conduction Heat Transfer",fullTitle:"Convection and Conduction Heat Transfer"},signatures:"António Crespo",authors:[{id:"36414",title:"Dr.",name:"Antonio",middleName:null,surname:"Crespo",slug:"antonio-crespo",fullName:"Antonio Crespo"}]},{id:"20087",doi:"10.5772/21503",title:"Soliton-Like Lamb Waves in Layered Media",slug:"soliton-like-lamb-waves-in-layered-media",totalDownloads:1890,totalCrossrefCites:5,totalDimensionsCites:14,book:{slug:"waves-in-fluids-and-solids",title:"Waves in Fluids and Solids",fullTitle:"Waves in Fluids and Solids"},signatures:"I. Djeran-Maigre and S. V. Kuznetsov",authors:[{id:"43397",title:"Dr.",name:"Irini",middleName:null,surname:"Djeran-Maigre",slug:"irini-djeran-maigre",fullName:"Irini Djeran-Maigre"},{id:"43398",title:"Prof.",name:"Sergey",middleName:null,surname:"Kuznetsov",slug:"sergey-kuznetsov",fullName:"Sergey Kuznetsov"}]},{id:"20412",doi:"10.5772/21230",title:"Nonequilibrium Fluctuations in Micro-MHD Effects on Electrodeposition",slug:"nonequilibrium-fluctuations-in-micro-mhd-effects-on-electrodeposition",totalDownloads:1293,totalCrossrefCites:4,totalDimensionsCites:13,book:{slug:"heat-and-mass-transfer-modeling-and-simulation",title:"Heat and Mass Transfer",fullTitle:"Heat and Mass Transfer - Modeling and Simulation"},signatures:"Ryoichi Aogaki and Ryoichi Morimoto",authors:[{id:"42360",title:"Prof.",name:"Ryoichi",middleName:null,surname:"Aogaki",slug:"ryoichi-aogaki",fullName:"Ryoichi Aogaki"},{id:"54508",title:"Mr",name:"Ryoichi",middleName:null,surname:"Morimoto",slug:"ryoichi-morimoto",fullName:"Ryoichi Morimoto"}]}],mostDownloadedChaptersLast30Days:[{id:"25446",title:"Flow Instabilities in Mechanically Agitated Stirred Vessels",slug:"flow-instabilities-in-mechanically-agitated-stirred-vessels",totalDownloads:3148,totalCrossrefCites:1,totalDimensionsCites:1,book:{slug:"hydrodynamics-advanced-topics",title:"Hydrodynamics",fullTitle:"Hydrodynamics - Advanced Topics"},signatures:"Chiara Galletti and Elisabetta Brunazzi",authors:[{id:"75453",title:"Dr.",name:"Chiara",middleName:null,surname:"Galletti",slug:"chiara-galletti",fullName:"Chiara Galletti"},{id:"75834",title:"Prof.",name:"Elisabetta",middleName:null,surname:"Brunazzi",slug:"elisabetta-brunazzi",fullName:"Elisabetta Brunazzi"}]},{id:"48887",title:"Mass Transfer in Multiphase Systems",slug:"mass-transfer-in-multiphase-systems",totalDownloads:9565,totalCrossrefCites:5,totalDimensionsCites:5,book:{slug:"mass-transfer-advancement-in-process-modelling",title:"Mass Transfer",fullTitle:"Mass Transfer - Advancement in Process Modelling"},signatures:"Badie I. Morsi and Omar M. Basha",authors:[{id:"174420",title:"Prof.",name:"Badie I.",middleName:null,surname:"Morsi",slug:"badie-i.-morsi",fullName:"Badie I. Morsi"},{id:"174770",title:"Dr.",name:"Omar M.",middleName:null,surname:"Basha",slug:"omar-m.-basha",fullName:"Omar M. Basha"}]},{id:"25437",title:"One Dimensional Turbulent Transfer Using Random Square Waves – Scalar/Velocity and Velocity/Velocity Interactions",slug:"one-dimensional-turbulent-transfer-using-random-square-waves-scalar-velocity-and-velocity-velocity-i",totalDownloads:1558,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"hydrodynamics-advanced-topics",title:"Hydrodynamics",fullTitle:"Hydrodynamics - Advanced Topics"},signatures:"H. E. Schulz, G. B. Lopes Júnior, A. L. A. Simões and R. J. Lobosco",authors:[{id:"20241",title:"Prof.",name:"Harry",middleName:"Edmar",surname:"Schulz",slug:"harry-schulz",fullName:"Harry Schulz"}]},{id:"37156",title:"Characterization of the Bidirectional Vortex Using Particle Image Velocimetry",slug:"characterization-of-the-bidirectional-vortex-using-particle-image-velocimetry",totalDownloads:2144,totalCrossrefCites:0,totalDimensionsCites:2,book:{slug:"the-particle-image-velocimetry-characteristics-limits-and-possible-applications",title:"The Particle Image Velocimetry",fullTitle:"The Particle Image Velocimetry - Characteristics, Limits and Possible Applications"},signatures:"Brian A. Maicke and Joseph Majdalani",authors:[{id:"64718",title:"Prof.",name:"Joe",middleName:null,surname:"Majdalani",slug:"joe-majdalani",fullName:"Joe Majdalani"},{id:"111632",title:"Dr.",name:"Brian",middleName:null,surname:"Maicke",slug:"brian-maicke",fullName:"Brian Maicke"}]},{id:"25453",title:"Flow Evolution Mechanisms of Lid-Driven Cavities",slug:"flow-evolution-mechanisms-of-lid-driven-cavities",totalDownloads:2807,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"hydrodynamics-advanced-topics",title:"Hydrodynamics",fullTitle:"Hydrodynamics - Advanced Topics"},signatures:"José Rafael Toro and Sergio Pedraza R.",authors:[{id:"75766",title:"BSc.",name:"Sergio",middleName:null,surname:"Pedraza",slug:"sergio-pedraza",fullName:"Sergio Pedraza"},{id:"81379",title:"MSc.",name:"José Rafael",middleName:null,surname:"Toro",slug:"jose-rafael-toro",fullName:"José Rafael Toro"}]},{id:"37152",title:"Limits in Planar PIV Due to Individual Variations of Particle Image Intensities",slug:"limits-in-planar-piv-due-to-individual-variations-of-particle-image-intensities",totalDownloads:1841,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"the-particle-image-velocimetry-characteristics-limits-and-possible-applications",title:"The Particle Image Velocimetry",fullTitle:"The Particle Image Velocimetry - Characteristics, Limits and Possible Applications"},signatures:"Holger Nobach",authors:[{id:"101177",title:"Dr.",name:"Holger",middleName:null,surname:"Nobach",slug:"holger-nobach",fullName:"Holger Nobach"}]},{id:"22261",title:"Heat Transfer Analysis of Reinforced Concrete Beams Reinforced with GFRP Bars",slug:"heat-transfer-analysis-of-reinforced-concrete-beams-reinforced-with-gfrp-bars",totalDownloads:5694,totalCrossrefCites:1,totalDimensionsCites:1,book:{slug:"convection-and-conduction-heat-transfer",title:"Convection and Conduction Heat Transfer",fullTitle:"Convection and Conduction Heat Transfer"},signatures:"Rami A. Hawileh",authors:[{id:"46905",title:"Dr.",name:"Rami",middleName:null,surname:"Hawileh",slug:"rami-hawileh",fullName:"Rami Hawileh"}]},{id:"25439",title:"Nonautonomous Solitons: Applications from Nonlinear Optics to BEC and Hydrodynamics",slug:"nonautonomous-solitons-applications-from-nonlinear-optics-to-bec-and-hydrodynamics",totalDownloads:1522,totalCrossrefCites:1,totalDimensionsCites:11,book:{slug:"hydrodynamics-advanced-topics",title:"Hydrodynamics",fullTitle:"Hydrodynamics - Advanced Topics"},signatures:"T. L. Belyaeva and V. N. Serkin",authors:[{id:"66736",title:"Prof.",name:"Vladimir",middleName:null,surname:"Serkin",slug:"vladimir-serkin",fullName:"Vladimir Serkin"},{id:"66765",title:"Prof.",name:"Tatyana",middleName:"Leonidovna",surname:"Belyaeva",slug:"tatyana-belyaeva",fullName:"Tatyana Belyaeva"}]},{id:"25450",title:"Hydrodynamics on Charged Superparamagnetic Microparticles in Water Suspension: Effects of Low-Confinement Conditions and Electrostatics Interactions",slug:"hydrodynamics-on-charged-superparamagnetic-microparticles-in-water-suspension-effects-of-low-confine",totalDownloads:1845,totalCrossrefCites:1,totalDimensionsCites:1,book:{slug:"hydrodynamics-advanced-topics",title:"Hydrodynamics",fullTitle:"Hydrodynamics - Advanced Topics"},signatures:"P. Domínguez-García and M.A. Rubio",authors:[{id:"68119",title:"Dr.",name:"Pablo",middleName:null,surname:"Domínguez-García",slug:"pablo-dominguez-garcia",fullName:"Pablo Domínguez-García"},{id:"75303",title:"Dr.",name:"Miguel Ángel",middleName:null,surname:"Rubio",slug:"miguel-angel-rubio",fullName:"Miguel Ángel Rubio"}]},{id:"25438",title:"Generalized Variational Principle for Dissipative Hydrodynamics: Shear Viscosity from Angular Momentum Relaxation in the Hydrodynamical Description of Continuum Mechanics",slug:"generalized-variational-principle-for-dissipative-hydrodynamics-shear-viscosity-from-angular-momentu",totalDownloads:1792,totalCrossrefCites:0,totalDimensionsCites:1,book:{slug:"hydrodynamics-advanced-topics",title:"Hydrodynamics",fullTitle:"Hydrodynamics - Advanced Topics"},signatures:"German A. Maximov",authors:[{id:"73783",title:"Dr.",name:"German",middleName:null,surname:"Maximov",slug:"german-maximov",fullName:"German Maximov"}]}],onlineFirstChaptersFilter:{topicSlug:"mechanical-engineering-fluid-dynamics",limit:3,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[{type:"book",id:"10176",title:"Microgrids and Local Energy Systems",subtitle:null,isOpenForSubmission:!0,hash:"c32b4a5351a88f263074b0d0ca813a9c",slug:null,bookSignature:"Prof. Nick Jenkins",coverURL:"https://cdn.intechopen.com/books/images_new/10176.jpg",editedByType:null,editors:[{id:"55219",title:"Prof.",name:"Nick",middleName:null,surname:"Jenkins",slug:"nick-jenkins",fullName:"Nick Jenkins"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:8,limit:8,total:1},route:{name:"chapter.detail",path:"/books/celiac-disease-and-non-celiac-gluten-sensitivity/are-gluten-free-foods-just-for-patients-with-a-gluten-related-disease-",hash:"",query:{},params:{book:"celiac-disease-and-non-celiac-gluten-sensitivity",chapter:"are-gluten-free-foods-just-for-patients-with-a-gluten-related-disease-"},fullPath:"/books/celiac-disease-and-non-celiac-gluten-sensitivity/are-gluten-free-foods-just-for-patients-with-a-gluten-related-disease-",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()